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Abstract 
 
Background 
 In 2010, a pilot program was implemented by the Medication Assessment Consultants 
(MAC) to provide comprehensive medication management (CMM) services to patients in the 
community of Saskatoon, Saskatchewan.  Clinical pharmacists working as consultants, 
independent of any retail pharmacy or health system organization, delivered the program.  The 
goal of the MAC CMM service was to optimize therapeutic outcomes for individual patients 
through improved medication use, and to reduce the risk of adverse drug reactions (ADRs).      
 
Purpose 
The purpose of this study was to evaluate the independent consultant pharmacist model 
for delivering comprehensive medication management (CMM) services employed by the 
Medication Assessment Consultants (MAC) pilot program. 
 
Methods 
A program evaluation was performed on MAC, consisting of a document review of 
program materials (e.g., MAC Policy and Procedure Manual, electronic patient records) along 
with stakeholder interviews.   
The document review consisted of the collection of existing MAC documents, followed 
by an analysis of the information contained within each document.   
Patients, physicians and MAC staff were interviewed using a semi-structured interview 
approach.  Patient and physician interviews were conducted by phone and by an interviewer 
external to the study.  Interviews were continued until saturation was reached.  The MAC staff 
was interviewed in person by the investigator.  All interviews were recorded and transcribed 
verbatim.  Thematic analysis was used to identify common themes by having three individuals 
independently review each group of stakeholder interview transcripts. 
 
Results 
During the 17-month pilot, 53 patients were referred to MAC, mostly from family 
physicians (79.2%).  Patients were elderly (mean 71 years) and mostly female (67.9%).  On 
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average, patients were taking 13.3 medications and had 9.2 medical conditions.  For the 42 
patients for whom an assessment was completed, an average of 5.1 drug therapy problems 
(DTPs) per patient was identified.  The document review revealed that MAC did not achieve all 
of its internal program objectives (e.g., to generate a consistent flow of patient referrals; to 
promote the service to physicians and patients; and to improve medication-related short-term 
outcomes for patients). 
All three interview groups reported a high level of satisfaction and support for the 
program.  Interviewees described various ways in which they felt that they benefitted from the 
program, including medication regimen optimization (patients), support in dealing with complex 
medication regimens (physicians), and a strong sense of personal and professional satisfaction 
and fulfilment (MAC staff).  
The evaluation of the MAC program resulted in the identification of several program 
strengths (e.g., a strong, well-defined patient care process; an accessible service location; MAC 
pharmacist mentorship and support program), along with opportunities for improvement (e.g., 
expanded promotional activities; administrative support for the program; implementation of a 
formal satisfaction survey to obtain regular feedback from key stakeholders).   
 
Conclusion 
The results of this study suggest the independent consultant pharmacist model for the 
provision of CMM services has potential to be utilized as a new service delivery model (in 
addition to community pharmacies and primary health care teams) to provide CMM services in 
the primary health care system (PHCS).  The study findings have identified several strengths and 
opportunities for improvement, which may be useful for future attempts at implementing the 
CMM service model. 
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Chapter 1 
Introduction 
 
1.1  Statement of the Problem 
Comprehensive medication management (CMM) is a pharmacist-delivered service that 
has potential to improve medication use in the primary health care system (PHCS).  CMM is 
defined as: 
“…professional activities needed to meet the standard of care which ensures each 
patient’s medications (whether they are prescription, non-prescription, alternative, 
traditional, vitamins, or nutritional supplements) are individually assessed to determine 
that each medication is appropriate for the medical condition being treated, that the 
medication is being effective and achieving the goals established, that the medication is 
safe for the patient in the presence of co-morbidities and other medications the patient 
may be taking, and the patient is able and willing to take the medications as intended.  
This assessment is completed in a systematic and comprehensive manner.” 1 
 
This process of assessing medications for appropriateness and opportunities for optimization has 
previously been demonstrated to result in patient benefit.  CMM has been shown to identify 
previously unrecognized drug therapy problems,2,3,4,5,6 as well as help patients achieve targeted 
health measures, such as blood pressure7 and cholesterol levels.8  CMM can also help patients 
gain better control of their medical conditions resulting in better health outcomes.9,10,11,12 
 In Canada, numerous provinces have attempted to implement pharmacist-delivered CMM 
with limited success.  Primary health care team (PHCT) initiatives, in which co-located 
interprofessional teams are assembled, have been implemented on a limited basis in Alberta, 
Saskatchewan and Ontario to encourage collaboration and help make teams of health care 
providers (HCPs) more accessible to patients.  Many of these teams have recruited pharmacists 
who have provided CMM within their respective clinics.13  Unfortunately, pharmacists are not 
always included as members of every PHCT, nor are PHCTs available universally in Canada.  
Another approach to improving access to pharmacist-delivered CMM was piloted in both Alberta 
and British Columbia, in which community pharmacists provided the service.  The pilot projects 
were named the Alberta Pharmacy Practice Models Initiative (PPMI) and the British Columbia 
Medication Management Project (BCMMP), respectively.14, 15  Both projects were plagued with 
limited community pharmacist uptake due to time constraints, juggling dispensing 
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responsibilities with CMM services, and a lack of support from physicians, resulting in the 
service being delivered to a very small percentage of residents within each province.16, 17   
 It is therefore possible that relying on PHCTs and community pharmacies to provide 
CMM may result in limited patient access to this service.  Consequently, it would be useful to 
explore an additional service delivery model to facilitate the expanded access to CMM services 
within Canada.   
A consultant pharmacist-delivered CMM program was recently piloted in Saskatoon.  
The consultant pharmacist model entails a pharmacist working outside of the “traditional” 
community pharmacist role, but not as a co-located member of an interprofessional team.  
Consultant pharmacists typically practice as private contractors and are not employees of a 
pharmacy business (such as a community pharmacy) or a health care institution (such as a health 
region, clinic or hospital), and are commonly either paid on a fee-for-service basis or daily 
contract rate.  These consultant pharmacists offer clinical services that can take on many forms 
from educating patients on various health-related issues, to providing drug information, to 
performing CMM.  This model has the potential to expand access to CMM services in Canada, 
beyond the community pharmacy and PHCT settings. 
The new consultant pharmacist-delivered CMM service that was recently piloted in 
Saskatoon was called the Medication Assessment Consultants (MAC) and it launched in 
September 2011.  MAC provided CMM services to patients in Saskatoon, SK until February 
2013.  MAC, unlike previous models, positioned a salaried consultant pharmacist in an 
independent space (i.e., not in a community pharmacy, health centre or physician clinic) to 
provide CMM services to patients based on referrals from physicians, other HCPs or patient self-
referrals.  This new program was, to the best of our knowledge, the first of its kind in Canada and 
the CMM service delivery model had been previously untested in the literature. 
 
1.2  Purpose of the Study 
 The purpose of this study was to evaluate the independent consultant pharmacist model 
for delivering CMM services employed by the MAC program.   
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1.3  Research Questions 
The following research questions were defined to achieve the study purpose: 
 
1. How does the Medication Assessment Consultant (MAC) program operate? 
1.1  How is the program promoted, delivered and managed? 
1.2  What resources are required to operate the program? 
1.3  What challenges exist in the operation of the program? 
 
2. How is the service utilized? 
2.1  How many patients were referred to the program and by whom? 
 2.2  What were the demographics of the patients who utilized the service, 
how many medications were they taking, and how many health 
conditions did they have upon referral to the program?     
 2.3  How many and what type of drug therapy problems (DTPs) were 
identified? 
 
3. What are the program objectives and is MAC achieving those objectives? 
 
4. What are the stakeholder experiences with MAC and what recommendations, if 
any, do stakeholders provide to improve the program?   
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Chapter 2 
Background and Literature Review 
 
2.1  Challenges Related to Medication Use  
 The number of medications available in Canada has been increasing dramatically for the 
past several decades18 and pharmaceuticals now represent the second largest health expenditure 
in Canada.19  Drug therapy has many benefits including its ability to prolong life and increase its 
quality, and often drug therapy is more cost-effective and less invasive than surgery and other 
medical procedures.18  Unfortunately, medications also contribute to a significant amount of 
patient harm,18 and this risk increases with the number of medications used.  Mannesse et al. 
demonstrated that the risk of severe or fatal adverse drug reactions (ADRs) increased as the 
number of medications prescribed increased, and that the simultaneous use of three or more 
drugs increased the odds of a severe ADR by 9.8 times.20  Another retrospective study showed 
that administering more than six drugs at a time was associated with a higher incidence of fatal 
ADRs; a total of 38.3% of patients with a fatal ADR were on more than six drugs compared with 
28.6% of patients with a nonfatal ADR.21  In another Canadian study, Forster et al. discovered 
that adverse events after hospital discharge due to medication occurred in 16.5% patients within 
30 days of discharge.22  The evidence also demonstrates that medication harm is preventable in 
many cases.  One Canadian study found that 24.0% of admissions to a hospital’s internal 
medicine service were found to be a direct result of medications, and over 70% of these 
medication-related admissions were deemed preventable.23  Another Canadian study found that 
one of every nine emergency department visits in a Canadian hospital was due to medications 
and over two-thirds were preventable.24   
 Not only is patient harm a concern with medication use, but there are also significant costs 
associated with the suboptimal use of medications.  In Canada, the total drug expenditure is 
estimated to have reached $32.0 billion in 2011 and $33.0 billion in 2012, representing annual 
growth rates of 4.0% and 3.3%, respectively.25  Total drug expenditure per capita reached $927 
in 2011 and $947 in 2012, representing annual growth rates of 2.9% and 2.2%, respectively.25  
Of the billions of dollars spent on drugs each year, the estimated cost of misuse, under use, and 
overuse of medications in Canada and the United States (US) ranges from $2 billion to $9 billion 
per year.26, 27  The impact and the management of ADRs is complex and in the US may cost up 
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to $30.1 billion annually.28  ADRs may increase costs due to increased hospitalization, 
prolongation of hospital stay and additional clinical investigations.  In addition, ADRs may 
trigger ‘prescription cascades’ when new medications are prescribed for symptoms that are a 
consequence of another medication, which is often an unrecognized ADR.28  Optimizing the use 
of medications and preventing ADRs has the potential to result in a significant amount of cost 
savings for both governments and individual patients. 
 
2.2  The Role of the Pharmacist in the Primary Health Care System (PHCS) 
  There is an opportunity for pharmacists to play a lead role in improving medication use, 
preventing ADRs, and reducing drug-related morbidity in the PHCS.  Evidence from multiple 
studies suggests that pharmacists can improve the safety of the medication-use system, and 
increase the rational use of medicines in primary health care.18, 29, 30, 31, 32, 33, 34  Unfortunately, 
many sources have highlighted the fact that pharmacists are a highly underutilized health 
resource, whose role needs to be expanded to improve medication management in the PHCS.35, 
36, 37 The Romanow Report specifically noted that,  
“Pharmacists can play an increasingly important role as part of the primary health care 
team, working with patients to ensure they are using medications appropriately and 
providing information to both physicians and patients about the effectiveness and 
appropriateness of certain drugs for certain conditions.” 26   
 
In Canada, both the Blueprint for Pharmacy and the Moving Forward: Pharmacy Human 
Resources for the Future documents conclude that it is time for the role of the pharmacist to 
evolve and move toward a more patient-centred model of care.18, 36   
 
2.3  Patient-Centred Care 
Generally speaking, patient-centred care is organized and prioritized around an individual 
patient.38  This model of care involves HCPs working with patients to identify and satisfy a range 
of patient needs and preferences.38  This approach to care supports the active involvement of 
patients, and possibly their families, in decision-making about individual options for treatment 
by respecting the patient’s values, preferences and expressed needs.39 
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2.4  Comprehensive Medication Management (CMM) 
CMM improves medication use and reduces the risk of medication-related is ADRs.2, 3, 4, 
5, 6, 10, 12  CMM is defined as:  
“The standard of care that ensures each patient’s medications are individually assessed 
to determine that each medication is: appropriate for the patient, effective for the medical 
condition, safe given the co-morbidities and other medications being taken, and able to 
be taken by the patient as intended” (p.5). 40    
 
Comprehensive medication management (CMM) is an example of pharmacist-delivered patient-
centred care focused on the patient’s medication experience, which consists of concerns related 
to medications, preferences for treatment, as well as beliefs and behaviours associated with 
medications.1  The overall goal of CMM is to optimize therapeutic outcomes through improved 
medication use and to reduce the risk of adverse events, including ADRs.2  Practically speaking, 
CMM occurs when a pharmacist (working collaboratively with the patient’s family physician) 
takes responsibility for the management of medications by meeting with patients regularly to 
perform comprehensive assessments of their drug therapy needs, and develop care plans that 
ensure the patient’s drug therapy needs are met, and resolve the any DTPs that were identified.  
Pharmacists who provide CMM typically meet with patients in an office-based setting (or in a 
private counselling room) on an appointment basis.    
There is a growing body of literature supporting the benefits of CMM.  Several studies 
based in Canada, the US and Australia have shown that this service, when provided by 
pharmacists, leads to a significant number of DTPs being identified and resolved (e.g., patients 
experiencing severe medication side effects; patients taking inappropriate drugs; patients who 
require drugs but are not receiving them).  These studies have produced similar rates of DTP 
identification with a mean of 2.3 to 2.8 DTPs identified per patient.3, 5, 6 
A specific example of pharmacist-led CMM delivery Canada was the Integrating Family 
Medicine and Pharmacy to Advance Primary Care Therapeutics (IMPACT) study, which aimed 
to improve drug therapy using a collaborative care model that integrated pharmacists 
(performing CMM) into PHCTs.4  This multi-site demonstration project involved seven 
pharmacists, approximately 70 family physicians and covered approximately 150,000 patients.4  
Over the course of the 24 months of the project, a comprehensive medication assessment was 
completed for 969 patients.4  Overall, a total of 3,974 DTPs were identified resulting in an 
average of 4.4 DTPs per patient.4 
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CMM has also been associated with a reduction in morbidity associated with heart 
failure.12  Ponniah et al. performed a systematic literature review and found various randomized 
controlled trials that demonstrated significantly fewer hospital readmissions for heart failure in 
the CMM intervention group as compared with the control group (24% vs. 59%, p<0.05) over a 
12-month period.12, 41 
Patients with Parkinson’s disease also appear to benefit from CMM.  In a 2012 study by 
Schröder et al., CMM improved the symptom-related impairment of health status (assessed using 
the 23-item Parkinson's Scale Total Score) in patients with Parkinson’s disease.10  This study 
also demonstrated a significant decrease in the proportion of patients receiving inappropriate 
drugs.  In the intervention group, there was a significant decrease over eight months in the 
proportion of patients over 70 years of age receiving inappropriate drugs as defined by the Beers 
List (42.9 % at baseline to 24.3 % at 8 months, p<0.01).10 
 
2.5  Acknowledgement of the Importance of Implementing CMM 
Implementation of CMM within the PHCS has been identified as a priority in several 
jurisdictions within both Canada and the US.  In Canada, two projects have been undertaken in 
both Alberta and British Columbia (BC) in an attempt to implement CMM.  Such large 
initiatives indicate that some Canadian health care system decision-makers recognize the 
importance of implementing CMM in Canada.  Each project is described in greater detail in the 
Section 2.6 entitled ‘Recent Attempts Implementing CMM in Canada’. 
The Patient-Centered Primary Care Collaborative (PCPCC) is an American organization 
that describes itself as an “open forum where health care stakeholders freely communicate and 
work together to improve the quality of care and ultimately the health of all Americans.”40  The 
PCPCC recognizes the value of CMM and as a result developed a 25 page guide entitled: “The 
Patient-Centered Medical Home: Integrating Comprehensive Medication Management to 
Optimize Patient Outcomes” that discusses the rationale for including CMM services in 
integrated patient-centred care.  Both Canadian and American health agencies recognize the 
potential benefits of CMM and have made this service a priority in their messages to 
stakeholders highlighting the benefits of CMM for patients and the health care system as a 
whole. 
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2.6  Recent Attempts to Implement CMM in Canada 
2.6.1  Community Pharmacies 
 
Alberta’s Pharmacy Practice Models Initiative (PPMI) 
In 2008, Alberta Health and Wellness launched an action plan to make the PHCS more 
efficient and effective.42  As part of this plan, they provided funding to organize a demonstration 
project, involving the implementation and evaluation of CMM in community pharmacies.14  
 When the initiative was completed in 2010, it was the largest pilot project in Canadian 
history that attempted to provide CMM within community pharmacies using existing employees 
of the pharmacies.16  During the period from March 1, 2009 until June 30, 2010, participants 
engaged a total of 18,623 patients in 33,993 encounters, resulting in the resolution of 39,517 
DTPs.42 
 Despite receiving remuneration for providing the service and a significant amount of 
support and training, over 95% of pharmacists in the study did not provide the service for a 
single patient.16  On average, the pharmacists who did provide the service only provided care for 
fewer than five patients per month due to various barriers such as limited time to provide CMM 
services while also tending to dispensing responsibilities, along with a lack of support from 
physicians.16   
 
British Columbia Medication Management Project (BCMMP) 
Shortly after the conclusion of the Alberta PPMI, BC began the pilot phase of their 
medication management project, BCMMP, in September 2010.  The purpose of the project was 
to improve patient care, health outcomes, and sustainability of the health care system by having 
pharmacists provide CMM to patients in the community pharmacy setting.43  The project allowed 
pharmacists to bill for their CMM services at rates that were adjusted based on the complexity of 
the patient encounter,17 in the same manner as the Alberta PPMI.   
On January 31, 2012 the data collection phase came to an end after 17 months.  Similar to 
the PPMI, the BCMMP had limited pharmacist uptake resulting in the service being provided to 
very few patients, even fewer than the Alberta PPMI.  Of the 1,116 community pharmacies in 
BC that were eligible to participate in the BCMMP in 2012,44 only 111 (~10%) actively 
participated in the project.17  Of the 3,927 community pharmacists in BC in 2012,44 only 243 
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(~6%) were active (or provided CMM services) in the BCMMP.17  In this project, pharmacists 
noted that providing both CMM services in addition to performing dispensing activities was a 
significant barrier in the provision of CMM services.17 
 
2.6.2  Primary Health Care Teams (PHCTs) 
A PHCT is an interprofessional group of HCPs who are responsible for delivering a range 
of health services and health programs targeting both medical and non-medical determinants of 
health through a collaborative model of care.45  PHCTs can be composed of numerous 
combinations of HCPs including physicians, pharmacists, nurse practitioners, social workers, 
dietitians, and many other specialties.  Saskatchewan, Alberta and Ontario formally utilize this 
model of health care delivery on a provincial level and have assembled significant numbers of 
PHCTs.49, 50, 51  
Within a PHCT, pharmacists have an important role to play in providing CMM, amongst 
other services, for the team and its patients.  Unfortunately, pharmacists are not always present 
on the PHCTs in Alberta, Saskatchewan and Ontario.  In Alberta, only 50 pharmacists (~1.3%) 
of the approximately 3,800 registered pharmacists work on a PHCT.46, 47, 48  In Saskatchewan, 
only 27.4% of the 90 PHCTs have a pharmacist on the team, and most are available only one day 
per week.55  Of the 1452 practising pharmacists in Saskatchewan only 1.7% work in PHCTs.49  
In Ontario, approximately 1.3% of practicing pharmacists work in a PHCT.50, 51 
 An additional limitation of the PHCT model for delivering CMM is that very few patients 
in Canada receive care from a PHCT and most utilize traditional family physician practices 
(without a pharmacist who provides CMM).  Only three provinces formally utilize this 
interprofessional model of a PHCT, and in the three provinces (Alberta, Saskatchewan and 
Ontario), the limited availability of PHCTs prevents access to all residents.  In Alberta, the goal 
was to have 80% of all Albertans receiving care from PHCT teams by 2011.52  Currently, there 
are only about 40 PHCTs operating throughout Alberta.52  In Saskatchewan, the Ministry of 
Health had planned to have 100% of Saskatchewan residents receiving care from an integrated 
PHCT team by 2012,53 yet only 33% of residents currently have access to a PHCT.54,55  In 
Ontario, from 2005 to 2010, 170 PHCTs had been created across the province, which were 
estimated to improve access to health care for more than 2.7 million Ontarians.50  The most 
recent Statistics Canada data estimate the population of the province of Ontario to be 
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approximately 13.5 million,54 meaning that only 20% of the Ontario residents have access to a 
PHCT. In August 2010, the Ontario government announced 30 more teams bringing the total 
number of PHCTs in Ontario to 200.50  While PHCTs are accessible to some Canadians, those 
with access most certainly represent the minority. 
 
2.7  CMM Implementation in Canada: What are the barriers? 
As described in Section 2.6, none of the previous attempts at implementing CMM into 
community pharmacy practice in Canada have led to widespread availability of the service. 
Clearly there are barriers that are preventing pharmacists from providing CMM in this setting.   
Two of the barriers noted in the Alberta PPMI were: time and effort to provide the service 
to patients and properly document in the patient record, while simultaneously tending to regular 
dispensing services; and the lack of support from physicians.16 
The BCMMP noted similar barriers.  Pharmacists also indicated that juggling their 
dispensing responsibilities with CMM services, was a significant barrier.17  Other barriers 
included: identifying and resolving medication management issues with complex patients; 
developing therapeutic relationships with patients; establishing a medication management 
practice; and building confidence in making recommendations.17 
Community pharmacies have historically only received remuneration for providing a drug 
product (and not a clinical service such as CMM).  As a result, community pharmacy owners and 
managers have developed a very efficient workflow and physical workspace to support the 
dispensation of a drug product, but not a clinical service like CMM.  A BC pharmacist, who 
participated in the BCMMP, was quoted:  
 
“Delivering enhanced pharmacy services requires each pharmacy to invest considerable 
time, effort and resources.  But fundamentally it requires the business model to be 
reassessed and developed so that providing these services is profitable and sustainable” 
(p.21). 17   
 
Adjusting this practice model to allow for the provision of CMM has proven to be 
difficult, which is supported by one of the findings of the PPMI project that the primary barrier 
to CMM provision was the need to alter their existing workflow to allow for the time to provide 
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patient care.  One pharmacist stated, “the pharmacy gets so busy (filling prescriptions) that I am 
mentally not prepared to sit down and discuss drug therapy problems with patients.” 16  
 Although the PHCT practice model has been implemented in some parts of Canada, the 
widespread expansion of this model has been extremely slow.  Even within the three provinces 
that have embraced this team-based model of primary health care service delivery, not all 
patients in the provinces receive care from these teams, and not all teams have funding to hire a 
pharmacist.  
It is unlikely that the majority of people in the Canadian PHCS will have access to CMM 
if the service continues to be provided exclusively by pharmacists who work as employees of 
community pharmacies or pharmacists who work as integrated members of PHCTs.  The 
identification of additional delivery models to provide CMM could assist in improving the 
availability of the service.   
Recently, a consultant pharmacist-delivered CMM service was created in Saskatoon, SK 
(called Medication Assessment Consultants or MAC), which is a model for delivering the service 
that has not previously been evaluated in the literature. 
 
2.8  The Evaluation of the Consultant Pharmacist-Delivered CMM Service Model 
The independent consultant pharmacist model involves a pharmacist working outside of 
the “traditional” community pharmacist role, but not as a co-located member of an 
interprofessional team.  Independent consultant pharmacists typically practice as private 
contractors and are not employees of a pharmacy business (such as a community pharmacy) or a 
health care institution (such as a health region, physician clinic or hospital), and are commonly 
either paid on a fee-for-service basis or daily contract rate.  Pharmacists working as consultant 
pharmacists offer a variety of clinical services from educating patients on various health-related 
issues, to providing drug information, to performing CMM.  The independent consultant model 
has been previously utilized by pharmacists to provide focused clinical services such as asthma 
education and women’s health consultations,56, 35 but it has not been previously evaluated for the 
provision of CMM in the primary health care system. 
 An opportunity to evaluate the consultant pharmacist-delivered CMM service model 
recently presented itself when a CMM service (called Medication Assessment Consultants or 
MAC) was piloted in Saskatoon from September 2011 to February 2013.  MAC, unlike any of 
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the previously tested models in the literature, positioned a consultant pharmacist in an 
independent space to provide CMM services to patients within the surrounding community.  The 
purpose of this study was to evaluate the independent consultant pharmacist model for delivering 
CMM services employed by the MAC program.   
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Chapter 3 
Methodology 
 
3.1  Study Design 
The study design was a focused program evaluation, which examined the MAC 
program’s operation between September 2011 and February 2013.  
Program evaluation is defined as the systematic gathering, analysis and reporting of data 
about a program to assist in decision-making.57  A program can be defined as “any series of 
activities, supported by a group of resources, intended to achieve specific outcomes among 
particular target groups.” 57  Programs can be of varying sizes, and can include projects, special 
initiatives, pilots, campaigns, or clinical services.57  The MAC program fits well into this 
definition of a program as it was a pilot project of a clinical service (CMM) designed to achieve 
the specific outcome of optimizing drug therapy.   
A program evaluation is intended to produce information about the performance of a 
program in achieving its objectives.58  Program evaluations enable researchers to describe the 
intended program, document what was actually implemented, describe participant characteristics, 
and demonstrate the impact of the program.57   
This MAC program evaluation consisted of a document review (methodology described 
in the next section), along with one-on-one interviews with the three main MAC stakeholder 
groups: patients, physicians, and staff (pharmacists and the program director).  This evaluation 
was performed for internal program quality improvement purposes to help inform the program 
staff of areas of strength and areas for improvement related to service delivery.   
The use of a mixed-methods approach consisting of multiple types of data (quantitative 
and qualitative), as well as multiple sources of data (documents and stakeholder interviews), 
enabled findings to be crosschecked and substantiated between the various sources to increase 
the credibility of the study’s findings. This process is formally termed triangulation in evaluation 
research.59  The aim of triangulation is to select multiple data sources and analysis techniques 
that have different biases and strengths, which improves the trustworthiness of the results when 
convergence is observed across these multiple sources.   
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3.2  Document Review 
Document review is a method of collecting data by reviewing existing documents from 
the program that is being evaluated.60  Documents may include reports, program logs, 
performance ratings, funding proposals, meeting minutes, newsletters, and marketing materials.60  
A document review can produce various types of information when used for the purpose of 
performing an evaluation and is important when the evaluation questions focus on whether the 
initiative was implemented as planned and who the participants were.59, 60  The purpose of the 
document review in this study was threefold: (1) to gather background information on the MAC 
program to understand and describe its operation including its promotion, delivery and 
management in order to answer the first research question related to how the MAC program 
operates; (2) to determine how the service was utilized and describe various factors related to the 
patient referrals including the number and sources of referrals, patient demographics, and DTPs 
identified in order to answer the second research question related to service utilization; and, (3) 
to determine if the actual service delivery aligned with the program’s objectives in order to 
answer the third research question related to the achievement of the program’s objectives. 
 
3.2.1  Document Identification and Collection 
The first step in the document review methodology was to identify and collect all relevant 
documents.60  The purpose of this initial step was to determine the types of documents that 
existed and to determine which documents would help in answering the research questions.60  
Four categories of documents related to the MAC program were identified for review: The MAC 
Policy and Procedure Manual, MAC promotional materials, the patient medical record and the 
pharmacist scheduling tool (web-based Google Calendar).  The MAC Policy and Procedure 
Manual contained numerous documents utilized in the operation of the program.  Once the 
documents from The MAC Policy and Procedure Manual, as well as all MAC promotional 
materials were identified, they were collected and summarized into a table, which allowed for the 
organization of the information contained within all of the identified documents.  Since the MAC 
patient medical record contained personal health information, in order to ensure the 
confidentiality of the patients, each patient file was de-identified and assigned a number to 
ensure any identifiable information such as name, health services number or address, would not 
be collected.  This information was summarized into a second table to again facilitate the 
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organization of the data.  A separate table was required for the patient data because the MAC 
patient medical record contained patient information that needed to be collected for each 
individual patient, and then quantified.  The collected data from the medical record included: 
patient sex and year of birth, the referral source (e.g., physician, nurse, etc), the number of 
medications as well as the number of health conditions the patient had at his or her first MAC 
appointment, and the number of DTPs identified by the pharmacist as part of the CMM 
provision.  The DTPs were further scrutinized to determine which of the eight DTP categories 
each fell into.  The eight categories included: (1) unnecessary drug therapy; (2) needs additional 
drug therapy; (3) wrong / inappropriate / ineffective drug; (4) dosage too low; (5) adverse drug 
reaction; (6) dose too high; (7) not following instructions / non-adherence; and (8) non-drug 
recommendations (e.g., request for lab tests). 
 
3.2.2  Data Analysis 
In analysing the MAC program’s documents, it was important to identify and confirm the 
purpose of each document along with the type of information each contained.60  In order to 
accomplish this task, the investigator reviewed each document noting the content of the 
document, and its purpose.  The investigator was also a service provider for MAC, so her 
familiarity with the documents eliminated the need to confirm the information with a member of 
the MAC team.  The investigator’s role in delivering the MAC services is explained further in 
the section entitled Researcher’s Story (Section 3.4). 
Determining the accuracy of the documents was also an important step in the document 
review process.60  This step was most relevant for the patient medical record since the data was 
entered by different pharmacists on multiple occasions, resulting in information that may have 
been uniquely or inconsistently documented by the different pharmacists.  The investigator and 
one of the MAC pharmacists analysed the patient medical record independently to confirm and 
agree on the accuracy of the following data: (1) the number of medications and health conditions 
for each patient referred to MAC; and (2) the number and category of DTPs identified per patient 
assessed by a MAC pharmacist.  Any discrepancies that were identified were discussed and 
resolved.  
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Statistical Analysis 
Descriptive statistics were used to describe the demographic data of patients who utilized 
the service.  All patient demographic data were analysed using SPSS 20.0 (SPSS Inc, Chicago, 
Ill).    
   
3.3  Stakeholder Interviews 
Three key stakeholder groups were identified for interviews: (1) patients, (2) physicians, 
and (3) MAC staff.  One-on-one semi-structured interviews were conducted with members of 
each stakeholder group using a unique interview guide for each group.  A semi-structured 
interview is a qualitative method of inquiry that combines a pre-determined set of open-ended 
questions (questions that prompt discussion) with the opportunity for the interviewer to explore 
particular themes, and to ask follow-up questions to further probe and clarify responses.59, 61, 62  
A semi-structured interview does not limit respondents to a set of pre-determined answers, unlike 
a structured questionnaire.61  Semi-structured interviews are used to understand how programs or 
interventions work, and how they could be improved.61  It also allows respondents to discuss and 
raise issues that the investigator may not have prospectively considered.61  
The purpose of the interviews was to gain insight into the experiences of the stakeholders 
involved with MAC in order to answer both the fourth research question not addressed by the 
document review (related to stakeholder recommendations), along with the first research 
question related to challenges in the program operation.  These interviews were necessary to 
determine the unique perspectives and experiences of all three stakeholder groups who played 
key roles in the MAC program to determine the aspects of the program that were working well, 
as well as those that may require alteration to help optimize service delivery. 
 
3.3.1  Selection of Interviewees 
Inclusion Criteria 
Patients 
To be included patients must have attended all scheduled MAC appointments (in person 
or via telephone).  The inclusion criteria ensured that the pool of potential interview participants 
would be composed of individuals who had experienced the full MAC service process enabling 
these individuals to comment on the entire service as it was intended to be delivered. 
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Physicians 
To be included physicians must have referred at least one patient to MAC, and that 
patient must have attended all of his or her scheduled appointments.  Similar to the Patient 
Inclusion Criteria, the intent was to ensure that potential physician interviewees experienced a 
complete encounter with the program including receiving a consult letter related to their patients’ 
drug therapy regimens, allowing the physicians to accurately comment on their experiences with 
the service.   
 
MAC staff 
All MAC staff were invited to participate in the interviews. 
 
Sample Selection and Sample Size 
Patients and Physicians 
A list of patients and physicians who met the inclusion criteria was provided to the 
interviewer by the investigator, and the interviewer contacted potential interviewees by randomly 
selecting individuals on the list provided. 
Interviews with both stakeholder groups were intended to continue until saturation was 
reached.  Saturation was defined in this study as the point in the data collection when each 
successive interview failed to produce new information that added additional insights to the 
research questions.59, 63, 64  The interviewer notified the investigator when he felt saturation of 
the interview data was reached.  It was at this point that all the interview transcriptions were 
reviewed by the investigator and her academic advisor to confirm together if saturation had in 
fact been reached.  Interviews were stopped when data saturation was reached.   
 
MAC Staff 
Due to the small number of individuals who composed the MAC staff, along with the 
unique experiences of each pharmacist, it was determined that it would be important to capture 
the experiences of all of the staff members.  The investigator intended to perform interviews will 
all three MAC staff. 
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3.3.2  Interview Guides 
 The development process for the interview guides involved multiple stages.  The initial 
stage entailed a search of the literature to determine if an interview guide already existed to help 
direct questioning during the evaluation of a CMM service.  Since no interview guides were 
identified, the investigator developed the interview guides.  To determine what type of 
information was required from each stakeholder group, the investigator and her academic advisor 
met on several occasions to discuss the issue to allow for the development of the interview 
questions.  Due to the absence of literature on the evaluation of a consultant pharmacist-
delivered CMM service, the investigator and her academic supervisor first had to determine what 
information needed to be gathered by the interviews.  From this point, interview questions could 
be developed to obtain this data from interviewees.  The final decision on the inclusion of 
specific questions was based on consensus.  For example, the investigator and her academic 
advisor decided that based on the research question related to the operation of MAC, they wanted 
to know how the service was promoted to stakeholders.  For the patient interview guide 
specifically, the question “How did you find out about the service?” was then developed.  Once 
all three interview guides were developed, they were comprehensively reviewed by the 
investigator and her academic advisor.  In addition, the patient interview guide was reviewed by 
an additional member of the research advisory committee.  This process resulted in the creation 
of three unique interview guides (Appendix A, B, C). 
The final step in the interview guide development was to pilot test both the patient and 
physician interview guides.  This was accomplished by having the interviewer perform a test 
interview with a faculty member of the College of Pharmacy and Nutrition not involved in the 
project that has an expertise in telephone interviews.  The interviewer performed an interview 
with the faculty member using both the patient and physician interview guide.  The faculty 
member provided feedback to improve the clarity of some of the questions.  The interview 
guides were revised based on this feedback. 
 
3.3.3  Interview Administration and Data Collection 
Patients and Physicians 
Patients and physicians were interviewed by telephone.  The interviewer who conducted 
all of the interviews was a pharmacist who had previous experience performing semi-structured 
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interviews, but was not a member of the research advisory committee, and was not involved in 
the MAC program service delivery. 
Patient and physician participants who met the inclusion criteria were contacted by phone 
by the interviewer to request their participation.  Potential physician participants were sent a fax 
a few days prior to the initial phone contact to inform them that the interviewer would be calling 
to request their participation in the study.  Using an Invitation to Participate script, the 
interviewer obtained verbal informed consent from participants prior to starting the interview.  A 
copy of the Invitation to Participate script is included in Appendix D (patient invitation) and 
Appendix E (physician invitation).  The interviewer also collected the participants’ mailing 
addresses so that detailed information about the study, along with investigator contact 
information could be sent to participants.  See Appendix F for the Patient Participant 
Information sheet and Appendix G for the Physician Participant Information sheet.  Participants 
who provided informed consent and completed an interview were mailed a $20 gift card as a 
token of appreciation for their participation.   
In order to ensure the quality and standardization of the interviews, the interviewer was 
informed about the details of the study and the purpose of the interviews.  To ensure that the 
interviewer was asking the interview questions correctly, and probing interviewees appropriately, 
the investigator and her academic advisor reviewed the transcriptions of the first patient and 
physician interviews to ensure the interviewer was following the expected interview protocol.  
Feedback was provided to the interviewer, prior to completing subsequent interviews, to ensure 
he was eliciting the appropriate information through further questioning and probing. 
 To protect the confidentiality of the patients and physicians, each interview was recorded 
and a transcribed verbatim externally, but with the removal of any identifiers such as names and 
locations.   
 
MAC Staff 
MAC staff members were contacted directly by the investigator (who was also a MAC 
staff member) and asked to participate.  See Appendix H for the MAC Staff Participant 
Information sheet.  MAC staff interview participants received a copy of the interview guide prior 
to the interview to allow them to review and reflect upon their responses.  The MAC staff 
interviews were conducted in person by the investigator at a time and location deemed 
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convenient for the participants.  The interviews were audio recorded and transcribed verbatim by 
the investigator.  The investigator, as a MAC staff member, responded to her interview questions 
in writing.  
 
3.3.4  Data Analysis 
Thematic analysis was used to identify common themes from the three sets of interview 
transcripts.  The first step in the analysis was to reduce the quantity of information through 
thematic coding.59  The purpose of the coding was to better understand the interaction of 
stakeholders with the MAC program by reducing the interview data into themes that explained 
the stakeholder experience. 
Various transcript analysers manually coded the transcripts using highlighters to identify 
key statements and common themes.  Three individuals, one of whom was always the 
investigator, independently reviewed each group of stakeholder interviews.  Patient and 
physician interviews were reviewed by the investigator, the MAC program director, and a 
member of the faculty of the College of Pharmacy and Nutrition (who was not a member of the 
research team or involved in MAC program service delivery).  The MAC staff interviews were 
reviewed by the investigator, the interviewer from the patient and physician interviews, and the 
same faculty member who reviewed the patient and physician interviews.  This mix of analysts 
was chosen based on their varied experience and expertise.  Three of the analysts were 
pharmacists, each with varying clinical experience.  The investigator and the MAC program 
director provided a familiarity of the program in the analysis of the transcripts; the faculty 
member, who was a non-pharmacist, provided a non-clinical perspective along with qualitative 
research expertise.   
All three transcript analysers read through the transcripts independently, highlighting the 
relevant or emerging themes in categories of interest that related back to the research questions.  
The transcript analysers were asked to identify text that related to: (1) what worked well; what 
could be improved and what challenges were identified; (2) suggestions made for improvements; 
and, (3) any other emerging themes that the analyst felt were relevant, but that were not captured 
by the previous three categories (see Appendix I for Instructions for Interview Transcript 
Analysers).  This thematic analysis was performed using open coding and line-by-line analysis.  
This form of coding involves a close examination of data, phrase-by-phrase and sometimes 
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word-by-word, with a comparison of the data for similarities and differences related to the pre-
defined categories.65  Data that were found to be conceptually similar in nature or related in 
meaning, were then grouped into major categories of information, 64, 65 for example, identifying 
what worked well or did not work well related to the CMM service.   
This process left the transcript analysers with transcripts containing text that was 
highlighted in various colours each signifying different categories (or themes) of information.  
Once the transcript analysers had completed the coding of the transcripts, they met as a group to 
discuss their findings and to develop and agree on the final common themes.  During the 
discussion, the transcript analysers revealed the themes they had each independently identified in 
the transcripts.  If all three analysers had identified the same theme, that theme was then 
accepted.  If not all three analysers identified the same theme, a discussion ensued to determine 
if, upon further review, a consensus could be reached regarding the existence of each theme or 
the wording of the theme.  If all three transcript analysers agreed to accept the debated theme, the 
theme was then accepted.  If all three transcript analysers did not agree that the theme was an 
accurate reflection of the interviewees’ comments, then it was discarded.  The process was 
repeated for each of the three stakeholder groups and a list of identified themes and sub-themes 
was generated. 
Once themes were defined within each stakeholder group by the transcript analysers, the 
investigator, along her academic advisor reviewed the interview transcripts comprehensively.  
The purpose of this review was to audit and verify the identified themes.  These two individuals 
read through all the transcripts to determine if the previously identified themes were accurate and 
unanimously agreed to any adjustments that needed to be made to the themes.  Once this process 
was complete, the investigator and her academic advisor generated the final list of themes along 
with their sub-themes (where applicable). 
 
3.3.5  Trustworthiness 
Several steps were taken to ensure the trustworthiness of the data and the data analysis, 
using a model proposed by Guba in 1981.  The process involves the identification of four aspects 
of trustworthiness that are relevant to both quantitative and qualitative studies: credibility, 
transferability, dependability, and confirmability.66, 67, 68 
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Credibility helps determine how congruent the findings are with relation to the real world 
and is one of the most important factors in establishing trustworthiness.67  One step to ensure 
credibility of data is to develop an early familiarity with the culture of participating organizations 
before the first data collection dialogues take place.66, 67, 68  Since the investigator was a 
pharmacist who directly provided the service within the program being evaluated, and had 
previous experience with delivering a similar service, a familiarity of the culture of physicians, 
patients and pharmacists was already present.  Another step that can be utilized to ensure 
credibility is triangulation.66, 67  As previously mentioned, triangulation entails using various data 
collection and analysis methods, and possibly obtaining supporting data from documents to help 
verify particular details that participants have supplied.67  The mixed methods approach of this 
study enabled the investigator to collect information through the application of a document 
review as well as through stakeholder interviews.  Triangulation was achieved within the 
interviewing process through the involvement of a wide range of study participants where 
individual viewpoints and experiences can be verified against others,67 as well as during the 
interview transcript analysis by utilizing multiple different transcript analysers who had to come 
to an agreement on the common themes.  Patients, physicians and pharmacists, each with unique 
experiences with the service, were interviewed to provide view points from all the stakeholders 
groups. 
When performing stakeholder interviews, it is recommended that strategies are 
implemented to ensure honest responses from interviewees.67  This can be achieved by providing 
potential participants with the opportunity to refuse to participate in the project so as to ensure 
that the data collection sessions involve only those who are genuinely willing to take part, and 
who are prepared to offer data freely, and that they are aware that they have the right to withdraw 
from the study at any point.67  When initially contacted by the interviewer, stakeholders were 
invited to participate in the interviews and were also informed of their right to withdraw at any 
time should they agree to be interviewed.  The final step taken to ensure credibility was peer 
scrutiny of the research project over the duration of the project.67  The investigator’s research 
advisory committee reviewed the research proposal and study results to ensure appropriate 
research methods were implemented and followed. 
The second aspect related to trustworthiness of data is transferability.66, 67, 68  
Transferability occurs when the investigator ensures that sufficient contextual information about 
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the phenomenon under investigation is provided to enable the reader to relate the findings to his 
or her own position.67, 68   After reading the description within the research report of the context 
in which the work was undertaken (e.g., a description of the MAC program), readers must 
determine if they can be confident in transferring the results and conclusions presented to other 
situations.67, 68  In order for this to be possible, it is important that the investigator provides a 
sufficiently thick or detailed description of the phenomenon under investigation to allow readers 
to have a proper understanding of it.67  The document review provided a detailed description of 
the program and its operation, and the patient data collected allows the reader to understand the 
demographics of those who utilized the service.  This information should allow for a reader to 
confidently decide if the results are transferable to his or her own situation. 
The third step in ensuring the trustworthiness of the data is to demonstrate 
dependability.66, 67, 68  To ensure dependability of the data, the process or methods within the 
study should be reported in detail, thereby enabling a future investigator to repeat the work, if not 
necessarily to gain the same results.67, 68  The methodology of this study have been described in 
detail above, and the data collection tools have been included to enable future investigators to 
apply them in a similar study. 
The final step in establishing trustworthiness is confirmability.66, 67, 68  Confirmability of 
data involves taking steps to help ensure that the work’s findings are the result of the experiences 
and ideas of the informants, rather than the characteristics and preferences (or biases) of the 
investigator.67  This process is strengthened through the use of triangulation and reflexivity.66, 67  
Triangulation was previously addressed. Reflexivity was examined in the Researcher’s Story in 
Section 3.4.   
 
3.4  Researcher’s Story 
 My interest in the research of pharmacist practice models comes from short, yet varied 
career as a pharmacist.  After completing a Bachelor’s of Science majoring in Psychology, I 
pursued my Bachelor’s of Science in Pharmacy.  As an undergraduate, I was not sure which 
practice environment best suited me, but was always drawn toward the pharmaceutical industry.  
After having the opportunity to work with a small pharmaceutical company for a summer, I 
decided that I had not found my passion and wondered where my career as a pharmacist was 
headed.  Upon the promise of generous funding to help support me through my undergraduate 
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degree, I signed a two-year contract with Shoppers Drug Mart.  My contract with Shoppers Drug 
Mart took me to Prince Albert, SK in 2008, which was a small community serving 
approximately 45,000 people.  I found myself working in an extremely busy store with a strong 
focus on checking prescriptions and fighting with insurance plans.  I quickly became dissatisfied 
with my work.  Fortunately, I was given the opportunity to work in the neighbouring physicians’ 
clinic one day a week.  I found it very rewarding to work closely with the patients and 
physicians.  Over time, I found that the physicians gained more trust in my skills and began 
coming to me with questions related to a variety of health conditions and their related drug 
therapy.  During the time I was working in the physicians’ clinic, I was also fortunate enough to 
join the provincial pharmacist advocacy body (Pharmacists Association of Saskatchewan) as a 
board member.  In this role I also became passionate about advocating for the expanded role of 
pharmacists as I felt pharmacists were not being utilized to their full potential.  I felt so fulfilled 
working directly with physicians and patients, and I wanted all pharmacists to have this 
opportunity.  It was then that I decided to return to school to pursue a Master’s of Science in 
Pharmacy.  As I began to explore my research options, the opportunity to participate in the 
evaluation of a new pharmacist practice model was extremely appealing.  I wanted to focus my 
research on a topic that I was passionate about and that would have practical application to my 
profession. 
My research project was developed to evaluate a new model for delivering CMM in 
primary care that had not yet been previously tested in Canada, and which was being developed 
and implemented under the supervision of my academic advisor.  Because I was a practicing 
pharmacist and there was limited funding to hire a dedicated pharmacist for the pilot project, I 
became one of the service providers for MAC, along with my role as program evaluation 
investigator.  Due to my passion for the profession and desire to demonstrate that pharmacists 
can be useful in a variety of settings, I had to be cautious to ensure my potential bias would not 
enter into my evaluation.  Several precautions were taken to keep my personal opinions and 
biases in check.  The quantitative data derived from patient medical records were double checked 
by a different pharmacist who was hired to assist in the delivery of the service, but who was not a 
member of the research advisory committee.  Interview questions in the semi-structured 
interview guides were reviewed by individuals external to the program to avoid any bias or 
influence in the questions.  The interviews were also performed by an external third party who 
 
 
25
was not involved in the service delivery or the research advisory committee.  Similarly, patient 
and physician interviews were transcribed and anonymized by an external transcriptionist.  
Finally, the transcribed interviews were analysed by multiple individuals and included 
individuals external to the research advisory committee with no formal link to the research 
project. 
 
3.5  Ethical Considerations 
On November 15, 2012 a research ethics application was submitted to the University of 
Saskatchewan Behavioural Research Ethics Board.  The research project was approved but 
deemed exempt from a comprehensive ethics board review on November 27, 2012 (BEH 12-
317).  The exemption was granted due to the project’s focus on program evaluation activities for 
the purpose of internal assessment and quality improvement. 
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Chapter 4 
Results 
 
4.1  Document Review and Analysis 
The documents analysed in the document review fell into four main categories:  
(1) documents contained within the MAC Policy and Procedure Manual;  
(2) promotional materials;  
(3) the patient medical records; and,  
(4) pharmacist scheduling tool (Google Calendar) 
Appendix J contains a comprehensive list of all the documents identified and analysed for 
the document review including the name of each document, the purpose of the document, and the 
type of information contained within the document.  Table 1 provides an overview of all of the 
documents in Appendix J that were utilized in the final analysis, highlighting the type of data 
that was analysed within each document.
 
 
27
Table 1: Overview of Document Review Analysis 
Documents Identified Data Analysed 
MAC Policy and Procedure Manual  
MAC Policy and Procedure Manual 
 Description of the MAC program (including 
the program objectives) 
 MAC pharmacist job description 
 Patient recruitment strategy and description of 
how the program was promoted to various 
stakeholder groups 
 Description of the patient referral process 
 Description of the patient appointment format 
and the process for patient care provision (i.e., 
CMM) by MAC pharmacists 
 List of resources required to deliver the service 
MAC Promotional Materials 
Patient brochure 
 
Promotional poster for physicians 
 
Miscellaneous documents (e.g., photos of 
conference displays) 
 
Physician referral form 
 Types of promotional materials used 
 Intended targets of promotional materials 
Patient Medical Records 
Electronic patient records (one for each 
patient referred to MAC) 
 
Web-based, shared, secure electronic data 
storage service (i.e, shared drive) 
 Patient referrals (quantity and sources) 
 Patient demographics, allergies, medication 
lists, list of medical conditions, laboratory 
results, and other relevant health information 
collected during the patient care process 
 Drug therapy problems identified by MAC 
pharmacists (type and quantity identified) 
Pharmacist Scheduling Tool (Google Calendar) 
Shared pharmacist calendar  Date of scheduled appointments 
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4.1.1  Description of Service Delivery and Program Operation 
 The first research question posed was: “How does the Medication Assessment Consultant 
program operate?”  This research question was designed to describe the program, its operation, 
its delivery, and its management.  It also was intended to determine the resources required to 
operate the program.  The following sub-sections outline these various attributes of the MAC 
program, which were determined through the document review data analysis. 
 
4.1.1.1  Medication Assessment Consultants or MAC 
MAC was a consultant pharmacist-delivered CMM service.  This means that the 
pharmacists were hired (and paid an hourly salary) as independent consultants, rather than 
employees of a community pharmacy, health region, hospital, or clinic.   
MAC was a mobile service and was able to deliver care in a large variety of locations, if 
required.  While MAC operated primary out of dedicated office-space (located in the Learning 
Centre of a Co-op Grocery Store), it was created so that it could travel to various locations that 
were convenient to the community.  MAC pharmacists were equipped with a laptop with 
independent Internet access (using a mobile Internet stick).  Pharmacists utilized a secure web-
based electronic medical record (EMR) to document their care and all patient documents not 
stored in the EMR (e.g., referral forms, medication lists, consult letters, faxes from physicians) 
were scanned and stored into a secure web-based data storage service.  MAC pharmacists were 
also equipped with a BpTRU© blood pressure monitor, a portable printer, and a cellular phone.  
 
4.1.1.2  Purpose of MAC 
MAC was created to provide access to CMM services for any HCP or patient in 
Saskatoon, SK.  The goal of a CMM service is to optimize therapeutic outcomes through 
improved medication use and to reduce the risk of ADRs.  
The program’s service objectives are listed below:  
1. To generate a consistent flow of patient referrals to occupy a pharmacist for two 
days per week (including patient interviews, researching the literature, 
documentation, and other related clinical service activities) 
o Specific MAC goal: To receive four new patient referrals per week, and 
perform four follow-up appointments per week. 
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2. To promote the service to physicians and eventually patients (no specific 
 timeframes or targets for the type or frequency of promotional activities  were 
pre-defined)  
3. To improve medication-related short-term outcomes for patients, as evidenced by: 
o The number of DTPs identified and resolved per patient (no specific target 
was pre-defined in MAC documents) 
o Description the types of DTPs identified by the pharmacist (no 
 specific target was pre-defined in MAC documents) 
 
4.1.1.3  MAC Operation and Funding 
MAC was run by the College of Pharmacy and Nutrition at the University of 
Saskatchewan and began accepting patient referrals in September 2011.  It was funded by a grant 
from the Drug Plan and Extended Benefits Branch of the Saskatchewan Ministry of Health.   
 
4.1.1.4  MAC Staff 
 MAC staff was composed of a program director and two pharmacists. The program 
director was also a full-time faculty member in the College of Pharmacy and Nutrition at the 
University of Saskatchewan.  MAC had no dedicated administrative staff or secretarial support.  
The two pharmacists were each responsible for providing the CMM service on a one-day-per-
week basis.  The pharmacists each had other primary employment.  They both also had 
additional training beyond a baccalaureate pharmacy degree, which was a requirement listed in 
the MAC Pharmacist Job Description, Responsibilities and Qualifications found in the MAC 
Policy and Procedure Manual.  One pharmacist had completed an acute care hospital residency 
and the other had completed the ADAPT Patient Care Skills Development program (by Canadian 
Pharmacists Association).  
 
4.1.1.5  Reporting Structure 
The reporting structure was such that all the pharmacists reported directly to the program 
director.  The program director was then responsible to report to the Dean of the College of 
Pharmacy and Nutrition. 
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4.1.1.6  Service Location 
 The service was provided in the Learning Centre of a Co-op Grocery Store located on 8th 
Street (a centrally located area) in Saskatoon, SK.  This space was located within the grocery 
store and was available for community-based programs free of charge.  The room was large, 
completely enclosed and private.  It contained tables and chairs that could be arranged in any 
formation users desired.  The Learning Centre booking was facilitated through the staff in the 
Co-op pharmacy, which was located directly across from the Learning Centre.  The space could 
be booked Monday through Friday between the hours of 9:00 a.m. and 10:00 p.m.  On the 
weekends, the room was available from 9:00 a.m. to 6:00 p.m. on Saturdays and 10:00 a.m. to 
6:00 p.m. on Sundays.  The Co-op Grocery Store offered a large parking lot with free parking.  It 
also did not have any stairs or elevations in the parking lot or within the building. 
 
4.1.1.7  Sources of Patient Referrals 
Referrals to MAC were accepted from any HCP, patient (by self-referral), caregiver or 
family member. 
 
Physicians and Other HCP Referrals 
Physician and other HCP referrals were made using a one page referral form (Appendix 
K), which asked for the contact information of the physician, the name and contact information 
for the patient, reason for referral, and for all relevant lab results and medical history.  This 
information, along with the referral form, was sent to MAC via a private fax line and was 
received by the MAC program director. 
   
Patient Self-Referrals and Non-HCP Referrals 
Patients self-referred by contacting the MAC office directly by phone to book an 
appointment.  Non-HCPs, such as caregivers and family members, were also able to refer people 
to the service by phoning MAC. 
 
4.1.1.8  MAC Patient Appointment Booking Process 
Patients referred by fax were contacted by telephone to arrange for an appointment.  
After the appointment was booked, the MAC program director mailed an informational brochure 
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(Appendix L) to the patient reminding them of the time and date of his or her appointment and 
which pharmacist the patient would be meeting with.  The brochure also explained the MAC 
program, what the patient could expect at his or her first appointment, and what to bring (e.g., all 
his or her medications). 
MAC did not have a dedicated scheduling system for managing and coordinating staff 
pharmacist schedules along with patient appointments, but rather utilized Google Calendar for 
both of these purposes.   
 
4.1.1.9  MAC Patient Appointment Format / Patient Care Process 
The CMM service was typically provided over a series of three appointments that lasted 
15 to 45 minutes.  The goal of the first appointment was to collect a detailed medication history 
from the patient including current and past medication use, medical conditions, medication 
allergies and intolerances, in addition to other lifestyle and social demographic information.  
This appointment always occurred in person.  Additional patient information was generally 
requested from the patient’s family physician following the first appointment (e.g., problem or 
diagnosis list, lab tests, diagnostic tests, specialist consult letters, clinical progress notes) that the 
pharmacist would require to complete the assessment.  The second appointment generally 
occurred one to two weeks after the initial appointment and was either completed in-person or by 
phone (for less complex cases).  The goal of the second appointment was to collect additional 
information from the patient regarding his or her medical conditions (e.g., level of disease 
control, symptom history) that could not be collected from the information that was requested 
from the family physician after the initial appointment, allowing the pharmacist to complete his 
or her assessment.  For less complex patients, these first two appointments were sometimes 
combined into one.  The goal of the third appointment (which usually took place over the phone 
as it was often much shorter than the first two appointments) was to discuss the findings or 
recommendations of the assessment with the patient.  Individualized medication education and 
adherence support was provided, as required, during all of the appointments.  After all three 
appointments were complete, a detailed consultation letter was sent to the family physician.  If 
recommendations were made to change the patient’s medication regimen, the patient was asked 
to make an appointment with the family physician to discuss the proposed recommendations.  
MAC pharmacists followed-up with the patients as often as necessary after the medication 
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assessment was complete, depending on the number of recommendations that were made, and 
whether or not all recommendations could be implemented at once.  All physician and patient 
communications were recorded in the MAC EMR.   
 
4.1.1.10  MAC Patient Assessment Process 
The pharmacists utilized various tools during the provision of the service.  The 
foundation of the service was the pharmaceutical care process.1  Pharmaceutical care is defined 
as “a practice in which the practitioner takes responsibility for a patient’s drug-related needs, 
and is held accountable for this commitment.” 1  This process was supported through the use of a 
standardized form (see Appendix M for the Medication Review Form).  The use of a 
standardized form ensured the pharmacist gathered all relevant information from the patient and 
that the assessment process utilized by each pharmacist was similar and comprehensive.  
The final “tool” utilized during the assessment process was a collaborative approach to 
managing challenging patient cases.  This was accomplished through discussions with the patient 
themselves, and possibly a caregiver, and the patient’s physician and/or community pharmacist.  
MAC pharmacists would also occasionally have team discussions when developing the care plan 
for particularly complex patients with multiple medication and health conditions.  The MAC 
team discussions involved at minimum, the MAC program director and the pharmacist who met 
with the patient to be discussed.  Often, a third member of the team would join in on the 
discussion. 
 
4.1.1.11  MAC Documentation Process 
All patient encounters were documented in an EMR.  When MAC launched in September 
of 2011, the pharmacists utilized an EMR called Assurance©.  This web-based EMR was used 
for the first few months as its cumbersome nature made it very time-consuming and difficult for 
the pharmacists to use efficiently.  It was eventually replaced with a simplified process in which 
electronic copies of all patient documents, MAC pharmacists’ progress notes and care plans, and 
consultation letters sent to physicians, were saved on a secure server that was accessible from 
any internet enabled device.     
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4.1.1.12  Description of MAC Service Promotion 
Patient Recruitment Strategy 
MAC was a new service to the city of Saskatoon and the MAC team had planned on 
developing ongoing promotion of the program to ensure that the stakeholders were aware of its 
existence and were reminded that it was available to support them.  While the MAC Policy and 
Procedure Manual stated that ongoing promotion would be vital to the success of the service, 
promotional efforts were strong in late 2011 and early 2012, but slowed significantly later into 
2012 and were no longer being pursued at all by late 2012 and early 2013.  The specific 
promotional activities, along with the dates they were performed, are discussed in the sections 
that follow. 
 
Physician-Focused Promotion 
Physician-focused promotion was recommended to be “ongoing” in the MAC Policy and 
Procedure Manual.  This manual indicated that various methods of promoting the MAC service 
to physicians would be used, including: 
 In-office physician educational detailing sessions 
 Setting up an informational booth at continuing medical education conferences 
 Presentations at physician group meetings 
 Direct mail outs to individual family physicians and group practices 
 
Table 2 summarizes the physician-focused promotional activities that actually took place 
and when they occurred. 
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Table 2: Physician-Focused Promotional Activities 
Date Promotional Activity 
Sept 12, 2011 
Physician detailing session at Kenderdine 
Medical Clinic (6 physicians participated) 
Sept 26, 2011 
Presentation at the Family Medicine 
Executive Meeting (35 physicians were in 
attendance) 
November 1, 2011  
Mail out to all family physicians in Saskatoon 
(included a copy of the referral form 
[Appendix K], a promotional poster 
[Appendix N], and a copy of frequently asked 
questions [Appendix O]) 
November 25 to 26, 2011 
Informational booth at a continuing medical 
education conference in Saskatoon (Practical 
Management of Common Medical Problems) 
January 10, 2012 
Physician detailing session at Lakeside 
Medical Clinic (11 physicians participated) 
January 19, 2012 
Physician detailing session at Erindale 
Medical Centre (6 physicians participated) 
January 25, 2012 
Physician detailing session at Queen Street 
Medical Group (number of physicians in 
attendance was not available) 
Mar 2 to 3, 2012 
Information booth at a continuing medical 
education conference (Peter & Anna 
Zbeetnoff Memorial Drug Therapy Decision 
Making) 
April 11, 2012 
Physician detailing session to individual 
family physician (1 physician participated) 
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Health Care Provider-Focused Promotion (non-physicians) 
HCP-focused promotion was also recommended to be “ongoing” in the MAC Policy and 
Procedure Manual.  It indicated that various methods of promoting MAC to non-physician HCPs 
would be used, including: 
 Explore partnerships with Saskatoon Health Region programs that may appreciate CMM 
support (e.g., Home Care, Geriatric Assessment Program, etc.) 
 Emails to professional organizations (e.g., pharmacy organizations such as Pharmacists 
Association of Saskatchewan) 
 
The MAC CMM service partnered with the Saskatoon Health Region Client/Patient 
Access Services (CPAS) in March 2012, which is a service that triages Health Region operated 
home support services (e.g., Home Care).  The partnership involved Home Care nurses 
identifying clients who were deemed at risk of a fall due to their medications, who were 
subsequently referred to MAC using a customized referral form (Appendix P).  No other 
partnerships with health region programs were identified. 
No evidence of formal promotional communications (i.e., letters, faxes) to non-physician 
professional organizations was identified in the document review; however, this analysis did not 
review less formal forms of communication such as personal emails, phone calls or informal 
meetings. 
 
Patient-Focused Promotion 
Patient-focused promotion was also recommended in the MAC Policy and Procedure 
Manual.  It indicated that different methods of promoting MAC to potential patients would be 
used, including posters in seniors’ high-rises, physician offices, and community centres; 
advertisements in senior-focused publications and shopping centres; information booths in 
locations with a high traffic of seniors (e.g., in malls located in close proximity to numerous 
retirement complexes). 
In analysing the various MAC documents, there is no evidence that any patient-focused 
promotion took place.  This finding was crossed-referenced with the results from the stakeholder 
interviews (Section 4.2) to confirm its accuracy.  Patient-focused promotional activities were not 
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identified in the stakeholder interviews either, suggesting these promotional activities did not in 
fact take place. 
 
4.1.1.13  Service Equipment and Other Related Resources Utilized to Operate MAC 
 Various pieces of service equipment and other resources were utilized in the provision of 
the CMM service.  Each item or resource played an important role and served a unique purpose 
(see Table 3). 
Table 3: Service Equipment Utilized and Its Purpose 
Operational Equipment/Resources 
Utilized 
Purpose of the Equipment/Resource 
Secure web-based EMR To securely store patient information 
Laptop computer 
To allow access to the EMR and other 
electronic resources 
Internet stick  
(i.e., remote access to internet) 
To facilitate a connection to electronic 
resources 
Printer 
To print patient consult notes and other 
documents 
Mobile phone 
For both incoming and outgoing calls to 
patients, physicians and MAC staff 
Fax machine 
To communicate with physicians (e.g., fax 
them the consult notes, receive lab data from 
physicians, etc.) 
Document shredder 
To securely discard of any printed materials 
that contained patient information  
Document scanner 
To facilitate the electronic storage of printed 
materials 
BpTRU© blood pressure monitor 
 
To allow the pharmacists to accurately 
measure patient’s blood pressure 
Private office space for patient 
appointments  
To conduct the service and ensure patient 
privacy 
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4.1.2.  Service Utilization and Patient Data 
 The second research question was “How is the service utilized?”  This question was 
intended to identify how many patient referrals MAC received, along with the source of the 
referrals and a detailed description of patient demographics, as well as the number and type of 
DTPs identified by the MAC pharmacists. 
The results of the data analysis from this portion of the document review are described in 
detail in the following sub-sections and are summarized in Appendix Q. 
 
4.1.2.1  Referral Numbers and Referral Sources 
Time Period of Referrals 
The MAC program accepted referrals between September 2011 and February 2013 (total 
of 17 months).  The first patient was referred on September 8th, 2011 and the final referral 
included in the data collection occurred on January 15th, 2013.   
 
Total Number of Referrals 
The total number of patients referred to the service (over 17 months) was 53. 
 
Sources of Referrals 
The majority of patient referrals to the program were made by family physicians (n=42, 
79.2%).  The additional referrals came from home care staff (n=7, 13.2%) and patient self-
referrals (n=4, 7.6%). 
 Twenty-three different physicians referred at least one patient.  The majority of 
physicians (n=13, 56.5%) who utilized the service only referred a single patient.  However, 
21.7% (n=5) of physicians referred two patients, 8.7% (n=2) referred three patients and 13.0% 
(n=3) referred four or more patients.  The most patients referred by a single physician were five.   
 
4.1.2.2  Patient Demographics, Medications and Health Conditions 
The patients who were referred to the program were mostly female (n=36, 67.9%).  
Patients ranged in age from 42 to 95 years (mean = 71 years). 
 The number of medications that patients were taking at their first appointment ranged 
from two to 31 (including prescription and over-the-counter medications, vitamin and mineral 
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supplements, and natural products), with a mean of 13.3.  See Table 4 for a summary of the 
number of medications being taken by patients at first appointment. 
 
Table 4: Number of Medications per Patient 
Number of Medications 
Recorded at First Appointment 
Number (%) of Patients  
2-5 5 (10.2%) 
6-10 15 (30.6%) 
11-15 10 (20.4%) 
16-20 10 (20.4%) 
21-25 7 (14.3%) 
>25 2 (4.1%) 
 
 The results in Table 4 account for 49 of the 53 referred patients.  Three patients declined 
participation in the program soon after referral, so their medication list was not collected.  One of 
these three patients who declined participation did so because he was recently assessed at the 
Geriatric Assessment Unit (GAU) (where comprehensive medication assessments are performed 
by an interdisciplinary team), but the reasons for the other two patients declining is not known.  
The fourth patient whose data is not included in Table 4 was referred to MAC by CPAS and only 
attended his first appointment (reason unknown for why he did not return to complete his 
assessment).  The patient was a poor historian and had recently switched to a new physician who 
did not have access to his previous health information; therefore his medication list could also 
not be confirmed. 
The number of health conditions or diagnoses per patient ranged from two to 21 (mean = 
9.2).  See Table 5 for a summary. 
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Table 5: Number of Health Condition or Diagnoses per Patient 
Number of Health Conditions/Diagnoses  Number (%) of Patients  
2-5 14 (28.6%) 
6-10 17 (34.7%) 
11-15 12 (24.5%) 
16-20 5 (10.2%) 
>20 1 (2.0%) 
 
Again, this information account for 49 of the 53 referred patients.  Missing data can be 
explained with the same rationale as the above medication data (Table 4) as it applies to the same 
four patients whose data is missing in that section. 
 
4.1.2.3  Drug Therapy Problems (DTPs) Identified 
A total of 215 DTPs were identified for the 42 patients (range of 0 to 13 DTPs per 
patient; mean of 5.1 per patient) for whom an assessment was completed and a consult note was 
sent to the physician.  Assessments were not completed for 11 of the 53 patients (20.8%) who 
were referred to MAC (and consequently consult notes were not sent to physicians, making it 
impossible to assess the number of DTPs identified) for the following reasons: patient declined 
participation in the service (n=3); patient unable to attend all appointments (four of whom lived 
greater than two hours outside of Saskatoon) (n=5); physicians did not forward adequate relevant 
medical history, preventing pharmacist from completing assessment (n=3).   
DTPs were categorized into one of eight categories (Table 6).  DTPs in the “Non-Drug 
Recommendations” category were exclusively related to the pharmacist requesting additional 
laboratory tests to monitor high-risk drug therapy. 
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Table 6: Drug Therapy Problems Identified Within Pharmacist Recommendations 
Drug Therapy Problem 
Number (%) of Individual DTPs within the 
Pharmacist Recommendations 
Unnecessary Drug Therapy 56 (26.0%) 
Needs Additional Drug Therapy 53 (24.7%) 
Wrong Drug 38 (17.7%) 
Dosage Too Low 13 (6.0%) 
Adverse Drug Reaction 11 (5.2%) 
Dose Too High  18 (8.4%) 
Not Following Instructions / Adherence 1 (0.5%) 
Non-Drug Recommendations 25 (11.6%) 
Total 215 
 
 
4.2  Stakeholder Perspectives 
 Interviews were completed with nine patients, five physicians and all three MAC staff 
(which consisted of two pharmacists and the program director).  Saturation of the data was 
observed in the physician and patient groups, so interviews were halted after five and nine 
interviews respectively.  The themes identified in the interviews with each stakeholder group are 
presented in the following sub-sections.   
 
4.2.1 Overview of Identified Themes 
Below is in an overview of all the themes and sub-themes identified in the stakeholder 
interviews. 
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Table 7: Summary of Themes Identified in the Stakeholder Interviews 
Theme Sub-Theme Patient Physician MAC 
Appointment Process X   
Service Location X X X 
Strong Patient Care Process  X  
Supports a Collaborative Approach  X  
Physician Communication   X 
Service 
Delivery 
Patient Communication   X 
Satisfaction 
and Support  X X X 
Overcoming Drug Coverage Barriers X X 
Medication Regimen Optimization X X Benefit to the Patient 
Patient Education X X 
X 
Benefit to 
Health Care 
Providers 
  X X 
Complex 
Patient 
Environment 
   X 
Service 
Promotion   X X 
Coordination   X 
Pharmacist Skills   X Internal Operations 
Logistics   X 
 
4.2.2  Patients 
 Three themes were identified in the patient interviews, which were: 
1. Service Delivery 
2. Satisfaction and Support 
3. Benefit to the Patient 
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4.2.2.1  Theme #1: Service Delivery 
Patient interviewees frequently discussed their perceptions and feedback regarding the 
manner in which the MAC service was delivered.  Overall, interviewees were happy and 
satisfied with the way the service was delivered.  Interviewee comments regarding MAC service 
delivery were most commonly related to two sub-themes: 1) the appointment process and 2) the 
location of the service.  
 
Sub-Theme #1: Appointment Process 
When discussing the appointment process, patient interviewees stated that they were 
appreciative that not all appointments required an in-person visit (i.e., some follow-up was 
performed by telephone).  Interviewees thought the referral process and appointment format was 
convenient and worked well for them, and that they experienced very little delay between 
referral and their first appointment.   
 
“Well what I appreciated, was that I could do some more over the phone…That just 
saved me money, also.  It saved me going.” (PT90) 
 
“Well it [time from referral to first appointment] was quite short actually.  It was 
probably less than 2 weeks.”  (PT87) 
 
“The whole process went a hell of a lot faster than I thought it would be.” (PT87) 
 
Patients were happy with the appointment process and did not identify any concerns with 
how the appointments were booked, the number and length of appointments, and the timing of 
the appointments.   
 
Sub-Theme #2: Service Location 
 Patient interviewees commonly stated that they were pleased with the fact that the MAC 
service was provided at an accessible location that was centrally located, easy to get to by car or 
public transit, and with plenty of free parking.  Many specifically mentioned that they were 
happy that the service was not located at a hospital, where many outpatient clinics in Saskatoon 
are commonly located.   
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 “Oh it was much better [location of the Co-op versus the hospital].  That was a great 
place to be.  Besides that the parking is free.  At the university hospital you almost have 
to take out a bank loan to park there.” (PT87) 
 
“… and the fact it was at the Co-op and you did not have to go to [the hospital] and pay 
a fortune and all that too helps.” (PT92) 
 
However, interviewees noted that it was not easy to find the location of the MAC office 
within the main building, as there was not sufficient signage to guide them. 
 
“I got there earlier, I know that the taxi driver took me right to the area, but it was an 
open room it was not chair and table organized or that type.  I sort of wondered if I was 
in the right place or not.  It would be good if there was some way of being absolutely sure 
you are in the right place.” (PT90) 
 
 
4.2.2.2  Theme #2: Satisfaction and Support 
 Patients expressed overall satisfaction with the MAC service and many had strong 
opinions that the service should continue to receive financial support to remain operational.  
Specifically, patient interviewees indicated that they had a positive experience when interacting 
with a MAC pharmacist.  Interviewees described their interactions with the pharmacists as very 
professional.  The patient comments indicate that the MAC pharmacists were patient-centred in 
their approach, had strong interpersonal skills, and were capable of creating a positive 
environment while building a relationship with the patients. 
 
“Your assessors were great people…  They were great.” (PT87) 
 
“… I just felt respected and you know, they even asked if I needed to take a drink or 
something.”  (PT90) 
 
“…the two people that interviewed me and took down the information, I thought that they 
were very professional and I kind of got a feeling that they knew what they were talking 
about and another comment, my doctor thinks highly of them.” (PT96) 
 
“Oh it was great friendliness, and respect, they did not put down my ideas and my 
opinions about things.  I was very impressed with each one of them.” (PT98) 
 
The patient interviewees also indicated that they valued the service.  They felt that it 
helped to prevent potential medication harm, that the pharmacists were able to address their 
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concerns in a timely fashion, and that the service had an impact on short-term outcomes 
including their quality of life.  Patients also stated that they appreciated the fact that the MAC 
pharmacists followed up after the initial appointments to determine if the desired outcomes of the 
recommended changes to drug therapy were occurring as planned. 
 
“…like I say I got a lot of revisions that worked and was relieved that someone was 
listening to me for a change.  Like I said I went through 6 months of hell and anyone who 
loses 60lbs due to diarrhea, nausea and you know throwing up, there is something really 
wrong.  I did not get it from my own doctor so that is why I asked to go because I knew.” 
(PT92) 
 
“I thought it was excellent… I was amazed at their dedication to calling me and seeing 
how things turned out.” (PT98) 
 
Overall, patient interviewees were happy with the service and the interaction they 
experienced with the MAC pharmacists.  The interviewees had a positive experience with the 
MAC service and were very satisfied and supportive of it. 
 
“It has been such a good experience.  The things that were wrong got straightened out.” 
(PT92) 
 
“Like I said, let’s just say I was very satisfied and have no complaints.” (PT95) 
 
 
4.2.2.3  Theme #3: Benefit to the Patient 
Patients commonly spoke about the benefits that they believed the MAC service had on 
their health and their medication regimens.  Interviewee comments regarding patient benefits 
most commonly related to three sub-themes: 1) overcoming drug coverage barriers, 2) 
medication regimen optimization, and 3) patient education. 
 
Sub-Theme #1: Overcoming Drug Coverage Barriers 
 Patient interviewees indicated that the MAC pharmacists assisted them in dealing with 
drug coverage challenges.  Where other HCPs had attempted to assist the patients with drug 
coverage barriers and had no success, the MAC pharmacists were often able to attain coverage.  
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“Well because of what they did, somehow they were able to get me a certain medication 
covered for me.  My pharmacist had tried and they could not get it covered but [the MAC 
pharmacist] somehow got it covered for me.” (PT90) 
 
 
Sub-Theme #2: Medication Regimen Optimization 
Patient interviewees provided insight into the impact the service had on their short-term 
clinical outcomes and their quality of life.  Through the optimization of patients’ medication 
therapy, the MAC pharmacists were able have a significant impact on the quality of life for some 
patients.  These improved outcomes occurred very soon after the implementation of the 
recommendations.  Through the identification of DTPs and the optimization of the medications 
being used to treat the various health conditions, the MAC pharmacists were able to assist many 
patients in regaining control of their symptoms and addressing problematic medication-related 
adverse effects.  
 
“They took me off the atenolol.  As soon as they took that off on the one day the next day I 
could walk 40 feet and not get dizzy instead of 3 feet… I had been taking that stuff for a 
long time.  All of a sudden it was gone and I felt like a human being again.” (PT87) 
 
“…thank the [MAC pharmacists] because prior to that I could not walk from the kitchen 
to the car without having to stop 3 times.” (PT87) 
 
“[The MAC pharmacist] had sent his recommendations to [my physician].  She thought 
that they were great.  Since then on the 20th, I have lost about 25lbs.  I was up a pound 
today, but I lost 25 pounds since the 20th.” (PT87) 
 
 “Oh yes [I think I benefitted from the service] because I was being over medicated 
beyond words.  My blood pressure was out of control, I had chronic diarrhea to the 
extreme I was scared of leaving the house at times.  I was nauseated, and this was all due 
to the medications I was on.  I had gout last March and they had me on 2 gout medicines 
which they were over dosing me to the extreme.  I lost 50lbs because of mismanagement 
of my drugs.” (PT92) 
 
“It was good they did it though because we had picked up on the fact I needed Fosamax 
to help prevent having breaking bones…I had originally been on it and then some doctor 
in the past took me off of it.  Nobody picked up on the fact that I should be back on it 
again.  So it was good that they have [the MAC service].  I feel a lot safer now.” (PT90) 
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Sub-Theme #3: Patient Education 
Through their interaction with a MAC pharmacist, patient interviewees indicated that 
they gained a better understanding of the medications they were using.  Patients were able to 
discuss and learn about the indications for, and benefits of, their current medications, as well as 
potential side effects. 
 
“Well, I learned about a lot of the pills I am taking, and aware of why I am taking them, 
and the side effects…” (PT96) 
 
 “… my sister had bought some things just on her own or ordered them from TV ads and 
stuff, and she explained why that is not such a good idea, and gave her the name of a 
better known product that would take the place of that.  That was helpful because my 
sister was very gullible with this stuff on TV.” (PT89) 
 
“Yes and my doctor was certainly happy about it because she felt she did not have 
enough knowledge about everything.” (PT90) 
 
 
4.2.3  Physicians 
 Five themes were identified in the physician interviews, which were: 
1. Service Delivery 
2. Satisfaction and Support 
3. Benefit to the Patient 
4. Benefit to Health Care Providers 
5. Service Promotion 
Three of the themes identified in the physician interviews, Service Delivery, Satisfaction 
and Support, and Benefit to the Patient, were also identified in the patient interviews (as 
discussed in the previous section, 4.2.2).   
 
4.2.3.1  Theme #1: Service Delivery 
Physician interviewees frequently discussed their perceptions regarding the manner in 
which the MAC service was delivered.  Overall, physician interviewees were happy with the way 
the service was delivered, and their comments regarding MAC service delivery related to three 
sub-themes: 1) a strong patient care process, 2) that MAC supports a collaborative approach, and 
3) the service location.  
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Sub-Theme #1: Strong Patient Care Process 
Various aspects of the patient care process were mentioned by the physician 
interviewees.  They noted that MAC utilized an empathetic, patient-centred approach during the 
patient assessments, which the physicians found to be quite thorough.  The physician 
interviewees also indicated that the CMM service provided practical recommendations that were 
presented in a clear and logical manner allowing physicians to easily follow and implement 
them.  The interviewees also commented on their communications with the MAC pharmacists, 
which were described as both effective and timely.  The physician interviewees also indicated 
that they felt the MAC pharmacists created a positive environment for patients to openly discuss 
their medications and related concerns. 
 
“The letters that are coming back are very concise and logical so it is an easy 
visit with the patients.” (MD101) 
 
 “…everyone was really nice and friendly and listened to them.” (MD86) 
 
“I feel that the patients were approached in a very respectful, non-judgmental manner 
and it is very important because some people become quite sensitive when they are on a 
number of medications, and you know have had the lecture, and that type of thing.  So I 
think the approach and the nature of the consultations are very, very well done.” 
(MD102) 
 
The physicians were also appreciative that the service delivery involved follow-up with 
patients once the implementation of the recommendations had begun.   
 
“Yes everyone got excellent follow up.” (MD91) 
 
Physician interviewees noted that the patient assessments involved a very detailed 
medication history and as a result, produced practical recommendations.   
 
“The pharmacist recommendations have been awesome.” (MD91) 
 
“…I have seen some good recommendations,…” (MD102) 
 
The organization and presentation of the information contained in the MAC consult note 
allowed physicians to easily follow and implement the plan.  The physicians also commented on 
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the value of being provided with alternate drug therapy options within the recommendations, 
should the initial recommendation not be effective.   
 
“They are very thorough and go through a very detailed medication history, and 
then giving some first suggestions and then also saying if that does not work we 
would recommend this as a second choice, and then also reaching follow up.  
Which I thought was great.” (MD86) 
 
“I think the way the consult came back, there was a number of options for 
different decision directions that could be made, and within each direction there 
was very step wise instructions, first of do this and then if this response is not 
achieved then try this.  So it was very nice in terms of how it was laid out which 
from my end of it trying to implement some of these changes, it made it very 
easy.” (MD101) 
 
Pharmacist-physician communication was noted by interviewees to be a strength of the 
service.  Physicians felt that they received the recommendations in a reasonable time frame.  
Interviewees also specifically mentioned that it was not a problem to contact the MAC 
pharmacist when needed.  
 
“…the feedback has been so prompt I have not felt the need to specifically 
phone [the MAC pharmacists].” (MD102)  
 
“Well for one of my patients, the pharmacist had sort of come up with 
something, and called me that day.” (MD86) 
 
 
Sub-Theme #2: Supports a Collaborative Approach 
 Physician interviewees indicated that the MAC service supported a collaborative 
approach to patient care by involving both the patient and the physician in medication therapy 
decisions.  The physicians viewed this collaborative and interprofessional approach to patient 
care as a program strength.  In one instance, a physician reported that he/she, the MAC 
pharmacist and the patient all came together to work through the patient’s various medication-
related problems as a team, and that he/she valued this experience. 
 
 “Because I got to meet with both the patient and the pharmacist together, think that it 
was good, and that it was a good team approach.” (MD97) 
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Sub-Theme #3: Service Location 
Physician interviewees, similar to the patient interviewees, frequently stated that they 
were pleased with the MAC service location and noted that it was a great site for patients to 
attend due to its central location and accessibility.  
 
4.2.3.2  Theme #2: Satisfaction and Support 
Similar to the patient interviewees, the physician interviewees expressed overall 
satisfaction with MAC and stated that the service should continue to receive financial support to 
remain operational, or even possibly expanded.  Physicians indicated that if the service were to 
continue beyond a pilot project, that they would continue to refer patients to the service.   
 
 “I really cannot tell you enough how much I think the program is awesome.” (MD91) 
 
“It has been an amazing experience.  I like it.” (MD91) 
 
“…I totally support [MAC] going on.” (MD97) 
 
“…and in one particular circumstance a patient of one of my colleagues who was on a 
long term medical leave as a result of surgery and I had taken over a couple of her 
patients to manage in her absence.  On her return, she had a comment like "what on 
earth did you do, he is fabulous”, so you know it was not just patients it was colleagues 
who were super pleased with things that I had done.  But, I had to give credit because it 
was not actually me.” (MD101) 
 
“I just hope they can get the continued funding, because on our end of it, it is a huge help 
for sure.” (MD101) 
 
 
4.2.3.3  Theme #3: Benefit to the Patient 
Similar to the patient interviewees, physicians indicated that their patients experienced an 
improvement in health outcomes as a result of the MAC service.  They also felt that their patients 
had a positive experience with MAC.   
 
“Well it was a very positive experience for the patient, and she was very appreciative.” 
(MD97) 
 
“I think everything was very practical and the outcomes were very good.” (MD101) 
 
 
 
50
Three sub-themes related to patient benefits were noted in the physician interviews 
(which were exactly the same as the three sub-themes in the patient interviews): 1) overcoming 
drug coverage barriers, 2) medication regimen optimization, and 3) patient education. 
 
Sub-Theme #1: Overcoming Drug Coverage Barriers 
The physician interviewees noted that the MAC service was able to assist patients in 
addressing and overcoming drug coverage barriers.  This ensured that patients were able to 
access the medications prescribed to them by their physicians when cost was a barrier to 
treatment. 
 
“We were trying to find an anti-nauseant for one of my patients, [the MAC pharmacist] 
…was able to get my patient the drug that day and we thought it was going to take some 
time before we would be able to get her onto a stronger anti-nauseant medication.  So 
that was fantastic.” (MD86)   
 
Sub-Theme #2: Medication Regimen Optimization 
When discussing the benefits to patients, the physicians commonly indicated that the 
MAC pharmacists were able to help optimize the medication regimens of patients through dose 
adjustments, recommendations for the initiation or discontinuation of medications, or the 
simplification of regimens.   
 
“…a lot of the times the medications were adjusted up or down, changed.” (MD91) 
 
“It cleaned [the patients’ medications] up, so less chance for interaction and side effects, 
that sort of thing.” (MD102) 
 
These actions resulted in improved medication-related care for patients, through the 
management of side effects and confirmed safety of medications, as alluded to by the physicians. 
 
 “… people I have referred have done amazingly well.” (MD91) 
 
“…it is nice to have someone who has experience with how all this interacts and are 
helping us to keep things clean and tidy, and functional, and safe.” (MD101) 
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Sub-Theme #3: Patient Education 
The final patient benefit identified by the physician interviewees was related to patient 
education.  The physicians felt that the service provided in-depth medication education to their 
patients, which they perceived as being valuable.  Physician interviewees mentioned that the 
education given to patients was comprehensive, useful, unbiased, and supported the appropriate 
use of medications.  Physicians also commented that the information provided to patients eased 
the implementation of changes related to the medication optimization since the patients had 
already received the necessary education along with an explanation of the rationale for 
medication changes from a MAC pharmacist.  
 
“… they provided some good education for her about her medications, and why she was 
taking them, and what they were for.” (MD86) 
 
“Obviously [the MAC pharmacist] spent time with them that I do not have, or that some 
other pharmacist did not spend with them to explain what their medications were for, and 
how to use it appropriately.” (MD91) 
 
 
4.2.3.4  Theme #4: Benefit to Health Care Providers 
The physician interviewees described the various ways in which they benefitted 
personally and professionally from their involvement with MAC.  Physicians indicated that they 
often struggle with time constraints when dealing with complex patients who have lengthy and 
detailed medical histories.  In such circumstances, the physicians reported that they felt MAC 
supported them by sorting through the medication-related information with the patient to 
determine suitable treatment options.   
 
“For my complex patients in particular, it is so hard to find the time to look through all 
their old records and find out what medications they have been on, and what their 
reactions have been, and do all of the research to find out what else we can try.  It is such 
a nice service.  I would be very sad if it was gone.” (MD86) 
 
Physicians also reported circumstances in which they were dealing with acute medical 
problems making them unable to focus on medication optimization, a situation in which the 
MAC pharmacists were also able to support physicians by researching and suggesting the best 
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treatments to physicians.  This process improved physician confidence by reassuring them that 
their patients’ medication therapy was optimized.   
 
“And I feel like my management with her is often to put out fires, and it was kind of hard 
for me to say well what are the gaps in her care.  It has been kind of overwhelming.  
When I sent her to the consultants, [the MAC pharmacist] found that she was not on a 
treatment for osteoporosis and they recommended [one].  I thought that was really 
beneficial because just between everything else going on with her, I do not know if I 
would have gotten there for quite some time.” (MD86) 
 
Physician interviewees commented on the benefits of having access to an expert opinion 
when it came to adjusting medications to ensure that the medications and corresponding dosages 
were appropriate, to confirm that drug interactions were managed, and that the medications could 
be used safely and effectively. 
 The physicians also viewed the information in the MAC pharmacists’ recommendations 
as a form of personal professional medication education, suggesting that they learned something 
from every patient referral that could be applied to other patients in their practice. This further 
improved physician confidence in the medication management of their patients.   
 
 “Yes what they gave me for one patient will carry over to another patient… So it is a 
nice refresher as well.  So it helps us to learn and the patients as well.” (MD102) 
  
4.2.3.5  Theme #5: Service Promotion 
 Physician interviewees indicated that while they were highly supportive of the program, 
they often forgot to refer many patients who likely would have benefitted.  They emphasized the 
fact that they would have appreciated a reminder to help cue them to refer patients to the 
program.  They also indicated that the promotion of the MAC program could be improved and 
provided some feedback related to how this could be achieved. 
The physician interviewees recommended using multiple different types of promotional 
materials to help increase the awareness of the program to both patients and referring physicians 
(e.g., posters in the waiting rooms and exam rooms).  They also felt that a patient brochure or 
pamphlet would be valuable to help explain to patients what could be expected from the service, 
where the service is located, and how to prepare for the first appointment.  The physicians 
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explained that a promotional brochure or pamphlet would serve not only to explain the service to 
patients, but would also help remind physicians to refer patients. 
 
“I think there could be a little more publicity about it.  Maybe a poster in a physician 
office that they can put on a wall in the waiting room while they are sitting and reflecting, 
even in the exam rooms that might help.  Because sometimes we are not even thinking 
about potential side effects, but if that was a visual inside the office, I think it would be 
helpful.” (MD102) 
 “A little brochure that says you will contact them, but here is where they are located, 
and this is what they can expect from the interview, and to bring all the medications with 
them.  Something simple. Plus if we had some kind of a little pamphlet that we could have 
would help us to remember to send to you.” (MD91) 
 
 Physicians also recommended that community pharmacists could help identify patients 
for referral to MAC based on pre-defined criteria, such as a specified number of medications. 
 
4.2.4  MAC Staff 
Seven themes were identified in the MAC pharmacist and program director interviews, 
which were: 
1. Service Delivery 
2. Satisfaction and Support 
3. Benefit to the Patient 
4. Benefit to Health Care Providers 
5. Complex Patient Environment 
6. Service Promotion 
7. Internal Operations 
Three of the themes were previously identified in the both the patient and physician 
interviews: Service Delivery, Benefit to the Patient, and Satisfaction and Support.  An additional 
two themes identified in the MAC staff interviews, Benefit to Health Care Providers, and 
Service Promotion, were also identified in the physician interviews.  An overview of all the 
identified themes from the stakeholder interviews is provided in Section 4.2.4. 
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4.2.4.1  Theme #1: Service Delivery 
MAC staff interviewees discussed their perceptions of the service delivery in great detail.  
The MAC staff also provided specific advice regarding how the CMM service could be 
improved, while highlighting the aspects of the service that they felt worked well.  Overall, 
interviewees were satisfied with the way they delivered the service.  Interviewee comments 
regarding MAC service delivery related to three sub-themes: 1) physician communication, 2) 
patient communication, and 3) service location. 
 
Sub-Theme #1: Physician Communication 
When it came to communicating with physicians, the MAC pharmacists indicated that the 
written form of communication (i.e., faxes) worked best for sharing their recommendations with 
physicians.  The written communications allowed the MAC pharmacists to effectively organize 
their recommendations, and also acted as an integral part of the patient record.  The only 
difficulty reported by the MAC pharmacists was the challenge of keeping the notes to a 
reasonable length. 
 
“Communicating in writing, often via fax, might be what worked best when it came to 
communicating with physicians.” (MAC2) 
“Using written forms of communication also helped created a sort of patient encounter 
record.” (MAC2) 
 
The pharmacists reported that patient assessments often resulted in multiple physician 
communications, which often involved a request for additional patient information.  The 
interviewees indicated that usually physicians promptly and consistently responded to requests 
for additional patient information.  This is confirmed by data from the document review (Sec 
4.1.2.3), which found that only 3/53 (5.7%) of patient referrals lacked adequate information from 
the physician, resulting in an incomplete assessment.     
 
“I often was pleasantly surprised by how quickly a physician might reply to a faxed 
request or return a phone call.”  (MAC2) 
“Using a mix of written and phone call communication certainly is key, especially when 
you need to ‘speed things up’.” (MAC2) 
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Sub-Theme #2: Patient Communication 
The MAC staff reported that patients were often introduced to the MAC program for the 
first time through a patient brochure, which was sent to them via the mail.  Sending out a patient 
brochure that explained what the MAC CMM service entailed and what patients could expect 
during their appointments, prior to their first appointment, helped patients better understand and 
value the service, according to the MAC interviewees.  The MAC staff felt that the brochure may 
also have helped address any unanswered questions related to the program.  They also believed 
that the patient brochure assisted in making patients feel more at ease with the new experience of 
attending a CMM service. 
 
“When I mentioned to patients that I was planning on sending them a brochure that 
would remind them of the appointment time, and the location, and the service and 
everything - they felt quite relieved because when I think I phoned them it was a lot of 
information to provide over the phone.” (MAC1) 
 
When it came to patient encounters, the MAC pharmacists stated that meeting with the 
patients in person was the best way to communicate.  The interviewees also commented that 
face-to-face interactions allowed the patient and pharmacist to develop a relationship more 
effectively.   
 
“I believe meeting with the patients in person on the first appointment is essential to 
creating a relationship of trust.”  (MAC3) 
 “I have had very positive experiences communicating with patients.  I think they are all 
very pleased to have the opportunity to sit down with someone to speak at length about 
their drug therapy.” (MAC3) 
 
While the importance of meeting patients in person, especially for a first appointment, 
was highlighted as being valuable to MAC pharmacists, they also felt that follow-up was an 
important part of the service.  The MAC pharmacists noted that brief phone calls could be made 
to patients to follow-up and that these calls were often quick, easy to perform and quite valuable. 
 Another comment made by the MAC staff was that they thought it was not easy for 
patients to contact them for unscheduled questions or concerns outside of the formal 
appointments, due to the part-time nature of the service.  The MAC staff indicated that 
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contacting the patients could also be a challenge.  Connecting with patients via phone was 
reported to sometimes be difficult without any dedicated administrative support.  
Finally, the MAC pharmacists also suggested that it would be beneficial to provide 
patients with a detailed list of their medications and important health history that they can keep 
with them, which was not a service that was typically provided for patients referred to MAC. 
  
Sub-Theme #3: Service Location 
The final topic that was noted within the theme of Service Delivery during the pharmacist 
interviews (which was also mentioned by physician and patient interviewees) was regarding the 
service location.  The pharmacists had several critical comments to make about the room in 
which they provided the service at the Co-op.  They felt the room was too large and consequently 
felt cold and uninviting (although this was not mentioned by patient interviewees who attended 
appointments in the room).  They also did not like the fact that it was a public space that had 
multiple users, which required that they set up the room with tables, chairs and other equipment 
prior to each clinic day.  The room also lacked good office furniture and an ideal waiting area.  
The pharmacists felt that the service would benefit from a dedicated service delivery location to 
help eliminate the need to repeatedly set up the shared space. 
 
“The room at the Co-op was good enough but not ideal.  I wouldn’t say it was 
comfortable per se, but it did the trick…it was slightly irritating to have to listen to 
overhead pages in a grocery store.  Temperature control was also sometimes a 
challenge…” (MAC2) 
 
“… the room itself wasn’t optimal.  It was really big, it was cold - it was used by multiple 
people and groups, so the pharmacist would have to set everything up when they got 
there.  It was a public space, it wasn’t an office, there was no good office furniture. I 
don’t think it looked nice.” (MAC1) 
 
The MAC staff also had positive comments regarding the service location, similar to 
patients and physicians.  They liked that it was centrally located, that it had lots of free parking, 
and was wheelchair accessible.  It also came free of charge, which was important considering the 
budget of MAC was very limited. 
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 “I think the location was awesome in that it was centrally located, and a place everyone 
knew where it was.  There was tons of free parking, there were no steps – so if you’re in a 
wheelchair – you couldn’t get a much more accessible location, I don’t think – and it was 
free so that was great.”  (MAC1) 
 
 
The MAC staff made several comments related to how they would alter the service 
delivery space in order to make it an ‘ideal’ space.  They recommended avoiding any stairs or a 
long walk to the service room, if at all possible, since most of the patients were elderly.  The 
MAC staff were mindful of the importance of a comfortable chair for patients that was easy to 
get in and out of, along with convenient access to amenities, such as a washroom.  They also 
recommended providing a comfortable waiting area for patients.   
 
4.2.4.2  Theme #2: Satisfaction and Support 
Similar to physician and patient interviewees, MAC staff reported overall satisfaction and 
support for the MAC program.  While the MAC pharmacists were satisfied with and supportive 
of the service, they recommended that it would have been valuable to seek regular physician 
feedback related to MAC services.  The pharmacists felt that the service lacked a formal 
satisfaction survey or quality assurance / evaluation process.  It was recommended that the MAC 
service should regularly seek physician feedback regarding various aspects of the service.  They 
also suggested that physicians who are not referring to the service could be asked for their 
reasons for not utilizing the service.   
 
 “I would love to see a more post-assessment feedback from physicians.  Either through 
phone call discussion, or by fax/email simply stating if the assessment was valuable and 
or how physician and patient have decided to implement recommendations.” (MAC3) 
 
The MAC pharmacists also reported personal and professional satisfaction and fulfilment 
through their involvement as members of the MAC team.  Improving the health of their patients 
through the assessment and resulting optimization of medications was rewarding for the MAC 
pharmacists. 
 
 “There is nothing more rewarding than fixing a problem for a patient that actually 
impacts their life in a way that is significant enough to say you’ve improved their quality 
of life.” (MAC2) 
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 “The best part is when a patient thanks you for solving a problem no one else could, or 
thanks you for making their life better.”  (MAC2) 
“Obviously, it’s pretty amazing when a patient comes back to you and says ‘meeting with 
you has changed my life’.” (MAC3) 
  
Not only was the MAC staff satisfied with their involvement in the CMM service, their 
interviews support the earlier finding that patients were also quite satisfied with their experience. 
 
“…one of the first things [patients] said when they phoned was how awesome the 
pharmacist was, what a great service this is, how wonderful they think it is that this is 
available...” (MAC1) 
 
4.2.4.3  Theme #3: Benefit to the Patient 
The MAC staff felt that the patients who were referred to MAC were appropriately 
complex to require the service.  In addition, similar to physician and patient interviewees, they 
stated that they believed the patient’s health status improved as a result of the service.  The 
pharmacists observed on several occasions where individual patient’s symptoms, risk factors or 
self-reported quality of life improved as a direct result of their interventions.   
 
“It seems that physicians tended to send us their ‘train wrecks’ however and these folks, 
and physicians, really needed our help.”  (MAC2) 
“The biggest impact on patients came from two situations – either a patient’s condition 
wasn’t controlled and we addressed that – and these situations were life altering 
symptoms like uncontrolled pain, severe and debilitating nausea causing weight loss.  Or 
the other situation was that a drug was causing an adverse effect that was affecting 
quality of life – one patient had such severe diarrhea that she was limited in leaving the 
house and had also suffered significant weight loss.” (MAC2)    
 
The MAC staff interviews offered several quotes to support the finding that patients’ 
quality of life was improved as a result of the service, and that drug therapy regimens were 
optimized.   
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“I think for some patients, it truly changed their lives for the better.  I can think of one 
patient in particular who was suffering from an adverse event and it was really affecting 
her life.  We addressed that problem and she was then able to do things she hadn’t been 
able to do for a long time.” (MAC2) 
“…some patients who had uncontrollable life-changing adverse effects, saw the reversal 
or the diminution of those adverse effects after seeing a MAC pharmacist which impacts 
their day to day.” (MAC3) 
 
4.2.4.4  Theme #4: Benefit to Health Care Providers 
The MAC pharmacists reported that the physicians appeared to appreciate the service 
they were providing (which was confirmed in the physician interviews).  The pharmacists were 
able to support physicians by addressing complex drug therapy regimens and by dedicating time 
to sorting through and collecting a detailed medication history from the patients.  The MAC 
pharmacists were then able to offer solutions to the identified DTPs.  As a result, the pharmacists 
felt that physicians were able to spend more time addressing non-medication-related patient 
concerns, and that patients received a greater depth of care. 
 
“I think we helped physicians who didn’t know what to do next in terms of drug therapy, 
physicians who didn’t have time to do a thorough examination of medications and 
physicians who just needed a second opinion on how to approach a drug therapy 
problem.  It certainly would save them time in the end and help them ensure that their 
patient is getting the best possible care through the optimization of their medications.” 
(MAC2) 
“…but I had physicians comment on, sort of spontaneously, about how much they 
appreciated the service – if I happened to see one or if for whatever reason they send a 
following referral - so I did get some informal feedback from the doctors about how 
valuable they saw the service to be .” (MAC1) 
 
4.2.4.5  Theme #5: Complex Patient Environment 
The MAC pharmacists reported that the program involved a complex patient environment 
in which a large majority of the patients referred to the service had multiple health conditions, 
were taking multiple medications, and as a result often had numerous DTPs.  This often 
challenged the MAC pharmacists to come up with the best course of action in terms of 
addressing the various DTPs that had been identified.  Presenting information in a way that 
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patients could easily understand was highlighted as a challenge due to the complex patient 
environment.   
 
4.2.4.6  Theme #6: Service Promotion 
The MAC staff felt that overall patient referral numbers were too low and that more 
referrals were desired.  Similar to physician interviewees, they stated that an improved and 
expanded promotion plan was probably required to increase referrals and ensure the success of 
the service, and they provided specific feedback related to how this could be improved.  In terms 
of physician-focused promotional activities, a variety of promotional materials and methods, 
including conference booths, mail outs, attending physician meetings, and offering physician 
office detailing sessions, were identified in the MAC staff interviews as options that could be 
employed to help promote MAC better.  The MAC staff believed that a combination of different 
promotional materials were important, which is consistent with the comments provided by 
physician interviewees. 
 
“And I think as far as promotion down the road, I think you need to use a variety of all 
these things all the time because this service is always going to be about promotion – if 
people don’t know about it, they’re not going to come to it.” (MAC1) 
 
The MAC staff also discussed how they felt that the service should have been promoted 
to HCPs other than just physicians, and that in the future, the target audience should also include 
pharmacists, particularly those in working in community pharmacies.   
The MAC pharmacists also specified that the service should have been promoted directly 
to patients who might self-refer to the service.  Seniors groups were identified as an ideal 
audience to target.  The MAC pharmacists believed that by placing brochures in physician 
waiting rooms, the awareness of the service among potential patients could have been increased.  
Also, mail outs to seniors groups, brochures in seniors’ high rises, and advertisements in senior-
directed publications were cited as excellent opportunities for promotion directly to patients.  
 
“I think individual patients would probably be better at identifying whether or not they 
would, not only appreciate the service, but benefit from the service if part of the 
promotion was explaining what the service was and generally who should be seen or who 
would benefit.” (MAC1) 
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‘Service branding’ was also identified by the MAC staff as being an important aspect to 
promotion.  The MAC interviewees stated that the MAC brand was valuable and that the MAC 
staff took measures to help establish this brand by ensuring it was on all the promotional and 
communication materials.  The MAC staff felt that with time, the MAC brand would gain 
recognition among physicians increasing both the credibility of the service and ideally the 
utilization of the service. 
 
“I think having a ‘branded’ letterhead was helpful in communicating with any 
stakeholder and that in time that brand would gain more recognition.  To see ‘MAC’ 
across the top of the consult note would help the receiver identify its source, and 
potential importance, right away upon first glance.” (MAC2) 
“I think it’s all about brand recognition really and the more you’re visible at multiple 
places like this, the more they’re going to remember you and the more credible you will 
be.” (MAC1) 
 
4.2.4.7  Theme #7: Internal Operations 
 Within the final identified theme of internal operations, three sub-themes were 
emphasized including: 1) coordination, 2) pharmacist skills, and 3) logistics. 
 
Sub-Theme #1: Coordination 
To facilitate the mobility of the service, and support the shared role of service delivery by 
the two different pharmacists, service equipment (e.g., laptop, BpTRU© monitor, etc.) was shared 
within the MAC team and often required MAC staff to coordinate the transfer of the equipment 
between pharmacists.  The MAC pharmacists commented that the successful management of 
shared equipment was a challenge as each pharmacist offered services on a different day 
requiring that the equipment be passed from one pharmacist to the other.  Since the program did 
not have a permanent service delivery space, the shared equipment could not be left in the 
service delivery room (it was used by multiple groups), and the equipment had to be left in a 
secured area to protect patient data.   
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Sub-Theme #2: Pharmacist Skills  
Various pharmacist skills, attributes and training were identified as being essential to the 
MAC program, and were credited (by MAC staff) for the success of the program.  Being capable 
of staying current with pharmacotherapy literature was one pharmacist attribute that was 
mentioned by the MAC staff as being important.  To help stay current, the pharmacists 
recommended attending provincial conferences that focus on drug therapy and/or the 
management of various medical conditions.  It was also felt that the successful delivery of the 
service was not completely dependent upon the pharmacist’s drug knowledge, but also upon his 
or her problem-solving skills.  Additional pharmacist training such as a hospital residency, 
Pharm D program, CPhA ADAPT program, or any training that supports the development of 
problem solving skills related to complex patients, were thought to be beneficial in the opinion of 
the MAC pharmacists and program director (and both pharmacists had additional training in 
these areas).  Being proficient in defining a focused clinical question, knowing how to search out 
the required medical information, as well as critically appraise the evidence in order to 
effectively address a patient’s DTPs, were other pharmacist skills that the MAC staff deemed 
necessary in the delivery of a successful service.  Additional pharmacist attributes identified 
during the MAC staff interviews that contributed to success of the service delivery included:  
common sense, an ability to effectively communicate with both physicians and patients, and the 
ability to self-assess and request additional support when needed.  The MAC staff believed that a 
successful MAC pharmacist would have to be confident, assertive, and comfortable being self-
directed as well as working independently.  The program director felt that the two MAC 
pharmacists had all of these skills and attributes and credited the success of the service to this 
fact.  It was recommended that any future staffing decisions should consider these important 
factors when selecting pharmacists to provide the service. 
 
“The pharmacists in MAC need a very strong set of professional skills, I don’t mean 
therapeutic knowledge, but professional skills around patient interviewing and the patient 
care process, and identifying patient drug therapy problems, creating care plans, all of 
that sort of process related professional pharmacist skills - absolutely need to be strong 
for this practice, not because you’re working very independently but because the patients 
are incredibly complex.” (MAC1) 
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Further comments made by the MAC staff interviewees related to the ideal pharmacist 
candidate for the delivery of CMM highlighted the value of experience delivering CMM 
services.  It was noted that with experience, a pharmacist becomes more proficient at delivering 
the service, which can involve a very complex patient environment requiring various skills in 
order to be proficient. 
The MAC staff also discussed how they served as a support to one another when dealing 
with complex patients.  Having support from a colleague, in which one could discuss difficult 
patient cases, was identified as being very valuable to the MAC pharmacists. 
 
“Having a support team in place to help you deal with complex patients is also 
important.  Having a sounding board to bounce ideas off of, or make sure you haven’t 
missed anything will certainly be beneficial to both the pharmacist and the patients.” 
(MAC2) 
 
 
Sub-Theme #3: Logistics 
Numerous comments and suggestions were made by the MAC staff regarding service 
logistics.  The first centred on the booking of patient appointments.  The staff felt that Google 
Calendar worked well to schedule patient appointments and pharmacist work hours since it was 
easy to use and access.  The main challenge of using Google Calendar was that it did not meet 
privacy and data security standards, which required MAC staff to assign patients random 
numbers within the Google Calendar schedule, rather than using their actual names.   
The booking of patient appointments by phone was identified as being the preferred 
method of communicating versus sending a letter informing patients that they have been referred 
to MAC.  The MAC staff indicated that calling patients also allowed for better tracking of which 
patient had or had not been booked.  However, the MAC staff felt that it would have been very 
helpful to have administrative support to assist with booking patient appointments.   
A second logistical comment that was identified in the pharmacist interviews was the 
importance of a standardized and clearly defined appointment process and format.  MAC had a 
standardized appointment format and interviewees felt that this ensured that all pharmacists were 
providing a consistently high quality service and allowed pharmacists new to the service to easily 
know what was required of them at each patient encounter.  The standardized process was also 
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acknowledged for ensuring that the pharmacist was thorough and did not miss any key 
information in the encounter.  
Another logistical challenge reported by the MAC staff was the EMR.  The EMR used 
initially, Assurance©, was described as being cumbersome, time-consuming and complex, 
requiring very detailed information to be entered into the patient record using a specific format 
through a defined sequence of prompts.  These software attributes made it difficult for the 
pharmacists to become proficient in entering data during a patient encounter.  The MAC staff 
stated that the success of any CMM service is dependent upon on a good documentation process, 
which required them to discontinue their use of Assurance© and move to using standardized data 
collection forms.  The MAC staff indicated that it would be beneficial to ensure that a user-
friendly EMR was utilized in a future program offering. 
 
“Being proficient in your documentation software is certainly vital to keep the 
appointment on track and ensuring that you’ve captured all the necessary information in 
the appropriate places.” (MAC2) 
 
 The MAC CMM services were delivered on a part-time basis (two pharmacists each 
working the equivalent of one day a week).  The MAC staff recognized that the part-time 
provision of the service was not ideal as it made communication with both patients and 
physicians difficult.  A full-time program with a dedicated pharmacist was recommended to 
alleviate both the communication and the aforementioned scheduling issues. 
 
 “The only way to do this is to have a full-time person who can take responsibility 
Monday to Friday for patient phone calls, provide more consistency of service and so 
they aren’t distracted by other employment priorities.” (MAC1) 
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Chapter 5 
Discussion 
 
5.1  Interpretation of the Program Evaluation Findings 
5.1.1  Triangulation of the Results 
To improve the trustworthiness of the findings, a mixed methods approach was applied 
that utilized multiple types of data (both quantitative and qualitative) that were collected from 
multiple sources through a document review and stakeholder interviews.  The multiple data types 
and sources offered different biases and strengths which helped improve the trustworthiness of 
the results.  In addition, multiple data analysts were used to interpret the qualitative data, 
including non-pharmacists who were not members of the research team, to limit the effects of 
researcher bias and to further strengthen the trustworthiness of the themes that were identified in 
the study.   
The most significant example of triangulation of the findings was apparent when several 
consistent themes were identified (by multiple data analysts) across different stakeholder 
interview groups.  Three of the seven final themes were common across all three stakeholder 
group interviews, which included: service delivery; high levels of satisfaction and support; and 
benefits of the program to the patients.  Two additional themes were consistent between the 
physician and MAC staff interviews (benefits of the program to HCPs, and service promotion).  
Considering that five of the seven themes were confirmed across more than one stakeholder 
group, the data from the interviews is likely quite credible and trustworthy.  
Triangulation of results was also noted between the qualitative and quantitative data.  For 
example, MAC interviewees stated that communication with physicians was strong and that 
requests for additional patient information from the family doctor’s medical chart were typically 
granted without delay.  This was confirmed by the document review, which found that only 5.7% 
of patient referrals lacked adequate information from the physician to complete the assessment.  
In addition, all three-stakeholder groups described the benefits that patients received from the 
MAC program, primarily as a result of optimized medication regimens and improved health 
status.  This qualitative finding was also confirmed by the document review, which found that 
MAC pharmacists identified, on average, more than five DTPs during each medication 
assessment.  In another example of triangulation, both physicians and MAC staff noted that the 
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program required an expanded promotional plan to be successful in the future, which is 
consistent with the document review data that found evidence of very limited and sporadic 
promotional activities during the 17 months of the pilot project.       
Consequently, the consistency of the findings across multiple data sources and data 
analysts suggests that the results of this study are trustworthy and credible.   
 
5.1.2 MAC Program Objectives 
One of the four research questions that this study aimed to answer was to identify the 
specific MAC program objectives and to assess if these objectives were achieved.  As identified 
in Section 4.1.1.2, the MAC program objectives were identified to be: 
1. To generate a consistent flow of referrals to occupy a pharmacist for two days per 
week (including research, documentation, and other related service activities) 
o Goal: To receive four new referrals per week, and perform four follow-up 
appointments per week. 
2.  To promote the service to physicians (and eventually patients) 
3. To improve medication-related short-term outcomes for patients, as evidenced by: 
o The number of DTPs identified and resolved per patient referred 
o Description the types of DTPs identified by the pharmacist 
 
The results of this study suggest that the first MAC program objective was not 
successfully achieved.  Over the 17-month evaluation period in which MAC was operational 
(September 2011 to February 2013), only 53 new patient referrals were received.  If MAC were 
to have met its first objective, it would have needed to receive approximately 292 referrals (73 
weeks of service x 4 new referrals per week).   
There are two possible explanations for why MAC did not achieve this first objective.  
First, the findings suggest that the MAC program may have been inadequately promoted to both 
physicians and the general public, possibly resulting in a limited awareness of the program.  The 
program evaluation found that promotional activities that focused on physicians were frequent 
and multi-faceted during the initial launch of the program, but were essentially non-existent by 
the end of the pilot.  Similarly, the program evaluation found that although MAC staff had 
planned to promote the service directly to the general public, no evidence of patient-focused 
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promotional activities were identified in the evaluation.  This is supported by the fact that 
physician and MAC staff interviewees provided clear and consistent feedback that MAC could 
have been promoted better.   
Additional data that support the theory that the MAC program did not achieve its first 
objective because of poor program promotion came from the physician interviewees who 
indicated that while they were supportive of the program and satisfied with the service, often 
forgot to refer many patients who likely would have benefitted.  They emphasized the fact that 
they would have appreciated a reminder to help cue them to refer more patients to the service. 
An alternate explanation for the low referral numbers is a possible lack of support for, or 
dissatisfaction with, the MAC service amongst the large group of stakeholders who did not 
participate in the stakeholder interviews.  The interviews excluded physicians who did not refer 
patients to the MAC service, and only 23 of the more than 250 family physicians in Saskatoon 
referred a patient to the service.  Consequently, it is plausible that the positive responses from the 
physicians who were selected for interviews do not represent the views of the majority of 
physicians in Saskatoon, who may have been unsupportive of the service.  In addition, patients 
who declined the service or did not attend all of their appointments, were excluded from the 
study, which also may have systematically eliminated individuals who may not have been 
satisfied with or supportive of the service.   
The small number of stakeholder interviews that were performed further raises suspicion 
that a representative sample of viewpoints may not have been collected and that the low referral 
numbers could be explained by a lack of support for, or dissatisfaction with, the MAC service 
amongst the large group of stakeholders who did not participate in the stakeholder interviews.  
Although the interviews were continued until data saturation was observed, which is a 
commonly utilized and accepted methodology utilized in program evaluation research, a very 
small number of interviews were ultimately completed (five physicians interviews and nine 
patient interviews), raising the possibility that the interviews failed to include the views of those 
who were dissatisfied with their MAC service experience, but who were not interested in 
volunteering for an interview.   
The finding that 56.6% of physicians who referred to MAC only referred a single patient 
provides additional support to the possibility that some physicians might not have been happy 
with the program and consequently did not refer multiple patients.  Unfortunately, since the 
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interviews were blinded, it is not possible to determine if the five physicians who participated in 
the study interviews (and who were very satisfied with and supportive of MAC) were those who 
referred a single patient or multiple patients.  Consequently, it is not possible to confirm from the 
results of this study if there was a large number of stakeholders who were dissatisfied with, or 
not supportive of the program, which resulted in referral rates that did not meet MAC targets.  
The results of this study suggest that the second MAC program objective, which focused 
on promotion of the MAC service, was also not successfully achieved.  Physician-focused 
promotion was found to be frequent and multi-faceted during the initial months of the pilot, but 
by the end it was very sporadic.  In addition, there was no evidence that promotion directed 
toward patients or other HCPs was performed.  Both physician and MAC staff interviewees also 
consistently remarked about the inadequate promotional plan and the need for improvement in 
this area.    
For the final MAC program objective associated with medication-related short-term 
outcomes, the results of this study suggest that it was successfully achieved, at least for the 42 
patients for whom an assessment was completed.  This conclusion can be made based on the 
high number of DTPs identified per patient (i.e., mean of 5.1) along with the data collected from 
the stakeholder interviews in which all three stakeholder groups consistently discussed the 
positive impact that the MAC program had on patient health outcomes.   
 
5.1.3  Insight Into the Independent Consultant Pharmacist Model 
Despite the fact that not all of the MAC program objectives were met at the end of the 
pilot project, the results of this study suggest that the independent consultant pharmacist service 
delivery model for providing CMM, which was utilized by the MAC program, has potential to be 
utilized as a new service delivery model (in addition to community pharmacies and primary 
health care teams) to provide CMM services in the primary health care system (PHCS).  This 
conclusion is made based on the following findings from the study: (1) the MAC service 
received on-going patient referrals throughout the duration of the pilot (albeit a small number) 
from multiple different sources, despite a lack of a coordinated and consistent promotional plan; 
(2) the assessments performed by the MAC pharmacists resulted in a large number of DTPs 
being identified in patients attending the MAC program; (3) very few patients who were referred 
to MAC declined the service (5.7%) or did not attend their appointments (9.4%); and, (4) the 
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consistently positive comments from all stakeholders who experienced the service, including the 
MAC staff.   
 
5.1.4  MAC Program Strengths  
The results of the program evaluation allow for some conclusions to be drawn regarding 
strengths of the MAC program.  These include: an accessible service location; a strong patient 
care process; effective communication with physicians; a collaborative approach to patient care; 
and skilled pharmacists who received a high level of support and mentorship.  These program 
attributes are discussed in more detail below.    
 
Location 
 An accessible office that is centrally located, provides free and accessible parking, and is 
easy to get to by car or public transportation was a definite strength of the MAC program.  While 
location and parking may initially seem to be trivial aspects of a health care service, the location 
of the MAC program, and the fact that it offered free parking that was very close to the 
appointment room, were mentioned consistently by all three stakeholder groups, indicating that it 
is an attribute of a service that stakeholders greatly valued.   
 
Strong Patient Care Process 
The data from the document review found that the MAC program trained its pharmacists 
to utilize a structured and consistent approach to their patient care process.  Over the course of 
the two to three standardized patient encounters, the pharmacists collected a detailed medication 
history from the patient, in addition to an in-depth discussion regarding the patient’s current 
medical conditions.  After the initial patient appointment(s), the MAC pharmacist often 
requested additional information from the patient’s physician in order to complete his or her 
assessment.  This was followed by a discussion with the patient related to the pharmacist’s 
recommendations and eventual referral back the physician to implement the recommendations.  
The results of the stakeholder interviews suggest that this clearly defined patient care process 
was a key strength of the MAC program.  The MAC staff also commented on how they valued 
the fact that the patient care process was standardized and clearly defined for them.  They felt 
that this standardization ensured that the MAC pharmacists provided a consistent level of service 
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and ensured that they did not miss gathering any key patient information during the assessments.  
This likely contributed to physician stakeholders’ comments in which they noted that patient 
assessments were thorough and resulted in practical, solution-focused recommendations.     
Overall, it is clear based on the results of this study, that the MAC program’s 
standardized patient care process was a strength of the program. 
 
Communication with Physicians 
The data from the stakeholder interviews found that communication between the 
physicians and the MAC pharmacists was both effective and timely.  The physicians felt that 
communications with the MAC staff were effective based largely on how the recommendations 
were presented to them.  The recommendations were described as being well organized and 
presented in an efficient manner allowing the physicians to easily follow and implement them.  
The physician stakeholders specifically noted this to be a strength of the program.  They also 
mentioned that contacting the MAC staff when necessary was not a problem. 
The MAC staff interviews also revealed some insight into their perspectives related to 
communicating with physicians.  The pharmacists indicated that the written form of 
communication (i.e., consult letters) allowed for the logical organization of their 
recommendations.  They also reported experiencing a prompt response from physicians when 
requesting additional patient information (a finding which was confirmed by the document 
review data). 
Consequently, effective communications between the MAC pharmacists and physicians 
was another strength of the MAC program. 
 
Collaborative Approach to Patient Care 
 The MAC program utilized a collaborative approach in the delivery of CMM services.  
The collaboration involved the MAC staff, the physician, and the patient in the problem-solving 
process to help foster support and understanding from all parties involved.  The physician 
interviewees stated that the MAC program supported a collaborative approach to patient care by 
involving both patients and physicians in shared decision-making related to drug therapy, 
supporting this conclusion.  Both the patient interviewees and MAC staff also commented on the 
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usefulness of this collaborative approach.  This collaborative approach was an additional strength 
of the MAC program. 
 
Skilled Pharmacists who Received a High Level of Support and Mentorship 
The results of the evaluation of the program indicate that the MAC pharmacists were 
skilled in the delivery of CMM services.  Comments from both patient and physician stakeholder 
interviews consistently support this fact by highlighting both the strong interpersonal skills, as 
well as the proficient professional skills of the MAC pharmacists.  The document review 
revealed that both MAC pharmacists had additional training above and beyond minimum 
Canadian entry to practice pharmacist credentials (one had completed a hospital pharmacy 
residency and the other had completed the ADAPT Certificate Program in Patient Care Skills).  
This was not a coincidence as the document review also found that the MAC Policy and 
Procedure Manual mandated that staff pharmacists have advanced skills and qualifications 
including: residency training or ADAPT certification; comprehensive medication management 
experience; and ideally an advanced degree, such as a Pharm D or MSc, or equivalent clinical 
practice experience.   
In addition to extra training, the MAC staff interviews also revealed that the mentorship 
and support system utilized by the program was considered important for the pharmacist’s 
performance and was attributed to MAC’s success in delivering CMM services.  The program 
director (who is a nationally recognized as an expert in the area of CMM services in primary 
care) provided regular support and mentorship to the MAC pharmacists.  In addition, the MAC 
staff interviews revealed that the entire MAC team met regularly to discuss challenging patient 
cases and complex clinical dilemmas, integrating a peer support program into the daily activities 
of the pharmacists. 
The results of this study suggest that the individual skills and performance of the 
pharmacists who provided the CMM service was a strength of the MAC program. 
 
5.1.5  Opportunities for MAC Program Improvement 
It is also important, for future MAC program delivery and for others who may want to 
replicate the program, to identify opportunities for improvement.  Some areas for program 
improvement that were identified in this study include: the need for administrative support; 
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securing dedicated office space; obtaining effective documentation tools; a strong program 
promotion plan; the need for more patient referrals; and the development of an on-going program 
evaluation process. These opportunities for improvements are discussed in detail below.   
 
Need for Administrative Support 
The MAC staff indicated that the lack of administrative support made it difficult to book 
patient appointments, coordinate communications with patients (e.g., to answer patient questions 
that arose outside of scheduled appointments), and schedule patient follow-up.  To overcome this 
challenge, it was suggested by the interviewees that administrative support be provided to 
improve these aspects of the program and to help the pharmacists focus on their primary role, 
patient care.  
 
Dedicated Office Space 
The MAC staff indicated that a dedicated service delivery location would be ideal.  The 
MAC staff used a shared public space throughout the pilot, which led to various challenges 
including reserving the space, repeatedly setting up the room with tables and chairs, and an 
inability to permanently alter the room to make it more comfortable and welcoming to patients.  
The interviewees suggested that a dedicated office space would overcome all these barriers, as 
well as eliminate the time the pharmacists spent travelling to and from the service location.  
Despite not having an “ideal” service delivery space (according to MAC staff), patients did not 
complain about the physical space in which their appointments were held (other than the fact that 
more signage was needed to help them find the office) and they reported a high level of overall 
satisfaction with the program, indicating that the physical and cosmetic appeal of the space was 
not a major factor for patients, and that location and parking were of highest value.   
The lack of dedicated office space also led to some logistical challenges encountered by 
the MAC staff throughout the pilot.  Since two part-time pharmacists delivered services one day 
per week, the coordination of shared equipment was a challenge (this included exchanging items 
such as the laptop and BpTRU© machine).  A dedicated office space would eliminate this 
challenge and equipment would no longer have to be transported to the service location.  This 
would further increase the efficiency of the service.   
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Consequently, finding and utilizing dedicated office space for the MAC program would 
improve the job satisfaction and efficiency of the MAC pharmacists, suggesting that it is an 
opportunity for improving the program.   
 
Effective Documentation Tools 
The MAC pharmacists commented that it would be valuable to identify a secure patient 
appointment scheduling system (other than Google Calendar), in addition to a user-friendly 
electric medical record (to allow the MAC pharmacists to efficiently document during patient 
encounters).  Documentation is vital in any health care service to track patient encounters, 
eliminate duplication of efforts, and allow HCPs to follow-up with patients appropriately and 
effectively.  Therefore, this is a key opportunity to improve the MAC program.   
   
Improved Program Promotion  
Physician interviewees specifically mentioned using a promotional brochure to support 
program promotion.  The MAC program did send a brochure to patients upon the booking of 
their first MAC appointment, but physicians were not made aware of this.  Also, physicians were 
sent a promotional letter explaining the MAC program, but did not specifically mention this 
during their interviews.  This finding supports the need for improved and on-going promotion to 
multiple stakeholder groups.  Physicians also indicated that they simply forgot to refer patients to 
the program, which also supports the need for on-going promotion of the program.  Improving 
physician-focused promotional activities, and expanding promotional efforts to patients and 
other HCPs are important areas of opportunity to increase the awareness of the MAC program. 
 
Increased Referral Rates 
If MAC is to continue beyond a pilot project and be successful, it must address the issue 
of low patient referral rates.  A recommendation provided by physicians to help increase new 
patient referrals to the program was to have community pharmacists identify patients who may 
benefit from the MAC program based on pre-defined criteria.  Community pharmacists were not 
a focus of promotional efforts during the MAC program pilot.  This group of HCPs would be an 
ideal target to which to promote the program to help increase awareness and as a result, 
potentially increase patient referrals. 
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During the MAC staff interviews, the staff specifically noted the problem of low patient 
referral rates.  The MAC staff desired more referrals and felt that the low numbers of referrals 
were a result of limited promotion.  This correlated with statements made by physicians, who 
recommended more promotion of the service to increase the awareness of the program.  Similar 
to the physician interviewees, the MAC staff suggested that promotional activities be targeted 
toward other HCPs beyond physicians, and that the program be promoted directly to patients in 
an effort to increase the number of patient referrals.   
It is beyond the scope of the results of this study to draw definitive conclusions regarding 
exactly why MAC patient referrals were low or how patient referral rates can be increased; 
however, increasing the number of patient referrals received by the MAC program is a key issue 
that must be addressed for future program improvement and sustainability. 
 
On-going Program Evaluation Process 
The MAC staff felt that the pilot program lacked a formal satisfaction survey or program 
evaluation process that would facilitate the opportunity to regularly identify program strengths 
and opportunities for improvement.  It was suggested that it would be particularly valuable to 
obtain regular feedback about the program from key stakeholders such as physicians and 
patients.  Ensuring that there is a process in place to allow for stakeholder feedback related to the 
program and its services would allow for continual program improvement so that it could better 
meet the needs of its stakeholders, suggesting that it is an opportunity for improving the program 
that is worthy of consideration.   
 
5.1.6  Relevance and Significance 
 The evaluation of this independent consultant pharmacist-delivered CMM service 
provides insight into the feasibility of this additional CMM service delivery model, which has 
not been previously evaluated anywhere in the world.  The results of this evaluation may be used 
for health service delivery decision-making within primary health systems to expand the 
availability of pharmacist-delivered CMM services.  
 
5.2  Study Limitations 
5.2.1  Lack of Critical or Negative Viewpoints 
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The consistent and positive responses about the MAC program that were received from 
all three stakeholder groups may not have provided a comprehensive understanding of the 
challenges related to the program and the comprehensive identification of opportunities for 
improvement.  While it is likely gratifying for MAC staff to determine that the program was 
well-received and valued by its stakeholders, an expanded understanding of the program’s 
potential drawbacks, would be equally useful from a quality improvement perspective.   
The stakeholder interviews produced such overall positive feedback, that it raises the 
possibility that the interview guides (developed by the investigator and her academic supervisor) 
may have biased responses toward the positive, and that the sampling strategy excluded those 
who had negative or critical opinions.  The lack of critical or negative viewpoints may in part be 
explained by a combination of the design of the interview guides, as well as the effects of the 
study’s inclusion criteria and/or by volunteer bias. 
The investigator and her academic supervisor designed the interview guides since no 
guide designed to evaluate a consultant pharmacist-delivered CMM service was identified in the 
literature.  The investigator also acted as a MAC pharmacist, and her academic supervisor was 
the MAC Program Director.  Based on the involvement of these two individuals in the delivery 
of the MAC program, it is possible that their biases toward a desire for a successful program 
could have entered into the interview guides.  
Of the 53 patients referred to the MAC program, 42 were eligible for a stakeholder 
interview based on the study inclusion criteria, which stated that only patients who had 
experienced the entire program service and attended all of their appointments were eligible for an 
interview (consequently 20.8% of patients [11/53] were not eligible for an interview). 
Considering that eight of the eleven patients who were not eligible were excluded because they 
either declined participation in the program or did not attend all their appointments, it is possible 
that some of the patients ineligible for an interview might not have been supportive of the 
program or had negative initial experiences. 
Another consideration is that a small number of Saskatoon physicians referred patients to 
the MAC program (only 23 of the approximately 250 family physicians working in Saskatoon at 
the time of the pilot project).  As a result of the low number of individual physicians referring to 
the service, the vast majority of physicians were excluded based on their lack of referrals. 
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In addition, a relatively small proportion of individuals in each group were ultimately 
interviewed (five of the 23 referring physicians and nine of the 53 referred patients).  This raises 
the possibility that volunteer bias may also have affected the results.  Volunteer bias refers to a 
specific bias that can occur when the individuals who volunteer to participate in a research 
project are different in some way from the general population.69  If this occurs, the researcher has 
sampled only a subset of the population, and consequently, the data gathered are not 
representative of all people, merely of those that choose to volunteer.69   Although both physician 
and patient interviews in this study were continued until data saturation was observed by 
multiple researchers, which is a very common approach used in qualitative research, it is possible 
that the limited number of interviews may have excluded individuals who were negative or 
unsupportive towards the MAC program. 
Future program evaluations should proactively attempt to collect more information about 
opportunities for improvement.  This could be achieved by either specifically asking 
stakeholders more detailed questions about program inadequacies, or by seeking out the 
viewpoints of stakeholders more likely to have negative experiences (e.g., patients who did not 
attend all of their appointments; physicians who referred only one patient or who did not refer at 
all).   
 
5.2.2 Unblinded MAC Staff Interviews 
Due to the small number of MAC staff interviews (two pharmacists and the program 
director), it was not possible to blind or anonymize the data.  Consequently, the two pharmacist 
interviewees were aware that their responses would not be anonymous and that the program 
director (i.e., their boss) would eventually read the collated themes that emerged from their 
responses.  Consequently, it is possible that some negative comments or experiences may not 
have been shared during these interviews, especially those regarding the performance of the 
director.    
 
5.2.3  Researcher Bias 
Since the investigator of this study was also a MAC pharmacist, there was potential for 
the personal biases of the researcher to enter into results of the study, as well as the data analysis.  
Since the program evaluation was intended to examine the activities of the MAC program, and 
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consequently the role of the investigator in her position as a pharmacist for the MAC program, 
there was a possibility that the investigator’s bias would lead her to seek out findings that 
resulted in a positive perspective related to the MAC program and the role of the pharmacists 
within that program.  The steps taken to minimize this potential researcher bias were previously 
described in detail in Section 3.4 entitled Researcher’s Story.   
 
5.2.4  Limitations of Using Drug Therapy Problems (DTPs) as an Endpoint 
 It is difficult to interpret the meaning of the number and types of DTPs identified by 
pharmacists during the medication assessments in this study, as well as their significance related 
to patient health outcomes.  It would have been preferable to measure the impact of the program 
on patient health outcomes using endpoints such as adverse drug reaction rates, emergency 
department visits, drug related hospitalizations or even indices of chronic disease management 
control (e.g., blood pressure, cholesterol); however, measuring these outcomes was beyond the 
scope of this research project.  It may have also been helpful to collect data regarding the 
seriousness or severity of the DTPs that were identified, but a validated scale for defining DTP 
severity in a primary care setting does not exist.  Finally, collecting information regarding 
whether or not each DTP was ultimately resolved would have also provided additional insight 
into the impact of the program on patient health outcomes, but the scope of the research project 
did not allow for an extended data collection period.       
 
5.2.5  Generalizability of the Results 
The first factor that may limit generalizability of the results of this program evaluation is 
that the MAC program interacted with patients who may have been more complex than those in 
the typical Canadian primary care population, based on their advanced age (mean of 71 years), 
their high number of medications (mean of 13.3 medications per patient), and their number of 
health conditions or diagnoses at the time of the first appointment (mean of 9.2 per patient).  
Recent Canadian data indicates that in 2012, seniors (those aged 65 or older) were taking an 
average of 7.4 medications each.70  In Saskatchewan, only 17% of seniors were taking ten to 14 
medications, and only 5.9% were taking 15 or more medications.70  Therefore, it appears that 
MAC patients were taking more medications than the average Canadian senior, thus would have 
more complex medication regimens, and therefore may not be exactly representative of a 
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“typical” patient population.  Consequently, it is unclear how the results of this program 
evaluation might apply to a less complex group of patients. 
Another consideration related to the generalizability of the findings is that the MAC staff 
pharmacists do likely not represent a typical Canadian pharmacist.  The MAC pharmacists both 
had advanced training (e.g., one pharmacist had an acute care pharmacy residency and the other 
had completed the ADAPT certificate program in patient care skills) that many pharmacists in 
the primary care system do not have.  In addition, the MAC pharmacists worked in an 
environment in which they had regular support and mentorship from an expert in the area (i.e., 
the program director) and other pharmacist colleagues.  Consequently, it is unclear if the results 
of this evaluation would be generalizable to pharmacists without additional training and to those 
practicing in a setting without significant mentorship and support.     
 
5.3 Future Research Opportunities 
A few key opportunities for further research were identified that would be worthwhile to 
pursue.  The first opportunity would be to increase physician-focused promotion and evaluate if 
these increased efforts resulted in increased physician referrals.  In addition, determining an 
effective way to remind physicians to refer patients to the service could have a significant impact 
on the number of referrals the physicians may generate. 
Another opportunity for future research is to proactively collect more information about 
critical viewpoints and opportunities for program improvement through a study re-design.  This 
could be achieved by either specifically asking stakeholders more detailed questions about 
program inadequacies, or by seeking out the viewpoints of stakeholders most likely to have 
negative experiences (e.g., patients who did not attend all of their appointments; physicians who 
referred only one patient or who did not refer at all).  Surveying non-referring physicians to 
determine why they have not referred may also be useful research to pursue.  Determining if it is 
due to the fact that they are unaware of the service, if they do not value the service, or if their 
patients decline referral when the physician mentions it to them, would provide great insight into 
increasing referrals in the future.  This will ensure that the overwhelmingly positive and 
supportive feedback collected during the stakeholder interviews are consistent with a larger 
sample of physicians and will determine if there are aspects of the program that need to be 
adjusted to appeal to a larger group of stakeholders.   
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Specific to CMM service delivery, it would be valuable to explore if patient assessments 
need to performed in-person in order to be effective and successful.  It would be useful to 
determine if patient assessments can be offered remotely (e.g., by telephone or video 
conference), and produce the same levels of quality and stakeholder satisfaction.  If it is found 
that CMM services which are offered remotely are just as successful as those offered face-to-
face, this would significantly increase access to CMM services for individuals not living within 
proximity of a CMM program. 
This study did not evaluate the cost effectiveness of this consultant model of delivering 
CMM in the PHCS, particularly in comparison with other models of delivering CMM (e.g., 
community pharmacies, PHCTs).  Therefore, a detailed economic evaluation would be useful for 
future research projects.     
Finally, future research could focus on measuring the impact of the program on patient 
health outcomes such as ADR rates, emergency department visits or drug related 
hospitalizations. 
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Chapter 6 
Conclusion 
  
The results of this study suggest the independent consultant pharmacist model for the 
provision of CMM services has potential to be utilized as a new service delivery model (in 
addition to community pharmacies and primary health care teams) to provide CMM services in 
the primary health care system (PHCS).  The study findings have identified several strengths and 
opportunities for improvement, which may be useful for future attempts at implementing the 
CMM service model. 
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Appendix A 
MAC Patients Interview Guide  
 
Expected duration of interview: 10 to 15 minutes 
Interview Questions for MAC Patients: 
Thinking about your experience with MAC….. 
How did you find out about the service? 
 Were you referred by your physician?  Hear about it from a friend? 
 
If your physician referred you, did he/she explain the service to you? 
 If not, would it have helped to know more about the service prior to your 
first appointment? 
 
What do you think worked well or not well in terms of: 
a. How appointments were booked? 
i. Did you receive an informational pamphlet about the service in the mail 
prior to your appointment?  What did you think about this pamphlet? 
 
b. Where the service was delivered? 
i. Did you find the location convenient?  Easy to find?  Parking?  
Accessibility? 
 
c. The number of appointments you had to attend? 
 
d. The length of the appointment? 
i. Too long?  Too short? 
 
e. The times of the appointment(s)? 
i. Did you meet with the pharmacist in the day or evening?  Did this work 
for you? 
ii. How long was it from the time you had initial contact/referral to your first 
appointment?  If delayed, what was the reason?  You couldn’t make it 
work with your schedule?  Or no appointments were available? 
 
f. The accessibility of the MAC team? 
i. Did you try to contact the MAC pharmacists outside of appointments?  
Was this easy? 
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g. Did you find the service valuable? 
i. Do you think this service resulted in an improvement in your medications? 
ii. Do you think this service resulted in an improvement of an understanding 
of your medications?   
 
h. How were you treated? 
i. Did you find the whole process overwhelming?  Do you feel you were 
involved in the decision-making? 
 
Are there any other areas that you thought worked well or not well? 
 
Would you recommend this service to others? Why or why not? 
 
Did you speak to your doctor about your appointment afterwards? 
 
How likely would you be to continue to see a MAC pharmacist on an as-needed basis? 
 
Do you have any other comments about the service you received? 
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Appendix B 
Physicians Interview Guide 
 
Expected duration of interview: 5 to 10 minutes 
Interview Questions for physicians who have referred to MAC: 
Thinking about your experience with MAC….. 
How did you find out about the service? 
 From a colleague?  At a continuing education event?  An in-office 
presentation? 
 
When you referred your patient(s) to the service, did you explain to them what they might 
expect? 
 What could MAC provide you with that would help explain the service to 
your patients?  
 
What do you think worked well or not well in terms of: 
a. The recommendations that you received from the MAC pharmacist? 
ii. Were they received in a reasonable timeframe? 
iii. Did you find the recommendations to be useful and practical? 
 Were you able to implement the recommendations? 
 
b. How the service affected your patient’s medications?  
 
c. How the service affected your patients understanding of his/her medications?  
 
d. Accessibility of the MAC pharmacists 
i. Did you try to contact the MAC pharmacists, and if so, did you encounter 
any difficulties?   
ii. Did you receive a timely response? 
 
e. Are there any other areas that you thought worked well or not well? 
 
What discussions, if any, occurred between you and your patient about the MAC appointment?  
In general, what was discussed? 
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Are you aware of any follow-up that your patient received from the MAC pharmacists?  If so, 
what was your reaction to this follow-up? 
 
What is the likelihood of you continuing to refer patients to this service? 
 
In your view, should this service be continued, discontinued or revised?  
 
Do you have any other comments about the service? 
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Appendix C 
MAC Staff Interview Guide  
 
Interview Questions: 
1. Physician Communication 
In answering the questions below, think about the various aspects of pharmacist-to-
physician communication that occurred through the delivery of the MAC services.  For 
example, communicating your recommendations to the physician; getting the necessary 
information from physicians (either from the referral or on request) - did physicians send 
enough information with the initial referral form, or did you often have to request further 
information? Did you ever request information and not receive it? 
Tell me about your experience communicating with physicians, whether it was via 
fax or phone.   
What about your experience communicating with physicians do you think worked 
well?   
What were some of the challenges you encountered in communicating with 
physicians? 
What would you do to improve pharmacist-to-physician communication?   
 
 
2. MAC Pharmacist Team Communication 
In answering the questions below, think about the various aspects of MAC pharmacist-to-
MAC pharmacist communication within the MAC team that occurred through the 
delivery of the MAC services.  For example, communication regarding whether an 
appointment had been booked; discussing difficult patient cases, etc. 
Tell me about your experience communicating with other MAC pharmacists. 
What about your experience communicating with other pharmacists within the 
MAC team do you think worked well?   
What were some of the challenges you encountered in communicating with your 
team? 
What would you do to improve MAC pharmacist-to-MAC pharmacist 
communication?   
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3. Patient Communication 
In answering the questions below, think about the various aspects of MAC pharmacist-to-
patient communication that occurred through the delivery of the MAC services.  For 
example, booking appointments; follow-up phone calls; in-person appointments; the 
cancellation of an appointment; discussing your recommendations; gathering necessary 
patient information from the patient; etc. 
Tell me about your experience communicating with patients. 
 
What about your experience communicating with patients do you think worked 
well?   
 
What were some of the challenges you encountered in communicating with your 
patients? 
 
What would you do to improve MAC pharmacist-to-patient communication?   
 
4. Patient Referrals & Drug Therapy Problems 
In terms of the patients who were referred to MAC (either by physicians, other 
HCPs, or self-referrals), do you think that the right patients were being referred to 
the service (i.e. did these patients require a medication assessment)? 
 
Do you think that patients who were referred to MAC benefited form the service? 
 
Was there any particular type of drug therapy problem that you noticed occurred 
most frequently?  Was there any particular drug therapy problem that you think 
had the greatest impact on patients when it was corrected? 
 
Do you feel that you were able to adequately address patient drug therapy 
problems? 
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5. Communication with Other Healthcare Providers (HCPs) 
In answering the questions below, think about the various aspects of MAC pharmacist-to-
other HCP communication that occurred through the delivery of the MAC services.  For 
example, communicating with home care – did you receive enough information from 
their referral? Communicating with community pharmacists - did they provide you with 
any further insight or information related to the patient who was referred to MAC? 
Tell me about your experience communicating with other healthcare providers (e.g. 
community pharmacists, home care staff). 
 
What about your experience communicating with other HCPs do you think worked 
well?   
 
What were some of the challenges you encountered in communicating with other 
HCPs? 
 
What would you do to improve communication with other HCPs?   
 
 
 
96
6. The Resources Used/Required to Deliver MAC Services  
In answering the questions below, think about the various resources used to deliver MAC 
services.  For example:  
o The MAC referral form used by physicians - did it provide the information 
required? Would you add or delete anything?   
o The patient brochure – did you find it valuable? 
o The use of Google calendar to coordinate appointments with both patient and 
pharmacist availability. 
o The space in which the service was delivered (i.e. the Co-op Community Room) - 
was it comfortable? Accessible? Private? Was it an appropriate space for service 
delivery? 
o Other resources available to you to deliver MAC services (e.g. EMR, laptop, 
cellphone, internet stick, printer, BPTru, extension cord, electronic resources, fax 
machine, shredder) 
 
Tell me about your experience with MAC resources (e.g. the referral form, the 
patient brochure, Google calendar, the Co-op Community Room, the EMR, the 
laptop, the cellphone, the internet stick, the printer, the BPTru machine, the 
extension cord, any electronic resources, fax machine, shredder, etc.). 
 
In your experience with the above resources what do you think worked well or was 
integral in service delivery?   
 
What were some of the challenges you encountered with the above resources?  
Would you say that any particular resource that you had access to was not required 
or necessary? 
 
What resources would you add to MAC services to improve the service?   
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7. MAC Service Delivery – The Process of Providing a Medication Assessment Service 
In answering the questions below, think about the process used to deliver MAC services.  
For example:  
o Contacting patients for their initial appointments – were patients easy to contact 
or get a hold of?  Were they expecting a call? Did you have to explain the 
service? 
o The appointment format - do you agree with the “defined MAC appointment 
format”? Were you able to follow it? How would you change it? Was follow-up 
easy or difficult? 
o Documentation – what is the best way to document (e.g. Assurance, your own 
forms, on paper)? Was it difficult to document during the encounter/follow-up 
phone calls? 
o Drug therapy problems – identifying problems, finding solutions, and prioritizing 
problems – was it easy or difficult?  How did you prioritize? 
o Consult notes to the physician – did you use the SOAP format?   
 
Tell me about your experience with the MAC service delivery process (e.g. 
contacting patients, the appointment format, documenting, identifying and 
addressing drug therapy problems, writing consult notes to physicians, etc.). 
 
What about your experience delivering MAC services do you think worked well or 
were integral in service delivery?   
 
What were some of the challenges you encountered with the above process?  Would 
you say that any particular process or step in service delivery was not required or 
necessary? 
 
What other processes would you add to MAC services to improve the service?   
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8. Perceived Service Value 
How do you think the MAC service most affected patients?  What about physicians? 
 
If given the opportunity to offer this service full-time, would you?  Did you enjoy the 
job?  Why or why not?  What was the best part?  What was the most difficult part? 
 
9. Service Promotion 
In answering the questions below, think about the various aspects of how MAC services were 
promoted to key stakeholders.  For example: 
o Conference booths – were they worthwhile (in terms of your time, the cost, the 
ability to discuss the service with others)?  Do you feel it generated interest and/or 
referrals? 
o Mail outs – do you think they were worthwhile (in terms to the cost and time 
required to prepare a mail out)?  Do you feel it generated interest and/or referrals? 
o Physician meetings – were they worthwhile to attend?  Do you feel it generated 
interest and/or referrals? 
o In-office physician detail sessions – were they worthwhile?  Do you feel it 
generated interest and/or referrals? 
 
Tell me about your experience promoting MAC services (e.g. conference booths, 
mail outs, attending physician meetings, in-office detail sessions, etc.). 
 
What about your experience promoting MAC services do you think worked well or 
were integral to increasing awareness of the service and possibly result in increased 
referrals?   
 
What were some of the challenges you encountered with service promotion?  Would 
you say that any particular “promotional tool” that was not useful or worth 
repeating? 
 
What would you recommend that MAC should do to promote the service that 
wasn’t done? 
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Appendix D 
Patient Invitation to Participate Script  
 
Hello – May I speak with Mrs./Miss. [last name]. 
This is [interviewer name] calling from the University of Saskatchewan, College of Pharmacy 
and Nutrition. I am calling regarding your recent experiences with a program within our College 
called Medication Assessment Consultants or MAC. I am working with a research team whose 
purpose is to evaluate the MAC service.  I am calling to see if you would be willing to participate 
in a 10 to 15 minute phone interview about the service. 
If you agree to participate, you will be compensated with a $20 gift card for the Co-op. 
You should be aware that there are no known or anticipated risks to you by participating in this 
research, and the possible benefits of the study, while not guaranteed, include contributing to the 
state of knowledge of such pharmacist-delivered services as MAC.   
Would you be interested in participating?  If now is not a good time for you, we can arrange a 
time and date that is convenient for you. 
 
If the answer is “No.”  Thank them for their time. 
 
If the answer is “Yes, but now is not a good time,” arrange for an agreed upon time and date to 
call back. 
 
If the answer is “Yes and now is a good time,” continue on with the script. 
 
The purpose of this interview is to collect feedback and gain a patient-perspective on the 
Medication Assessment Consultants (or MAC) service.  The questions are designed to help 
identify areas of the service that work well and should remain the same, as well as to identify 
areas that could be improved or changed.  You will be asked to answer several short questions.  
Your responses will be recorded and transcribed.   
All identifiers will be removed from the transcribed interviews.  Your physician and MAC 
pharmacist will only receive de-identified information.  This means they will not be able to 
connect or identify your responses with your identity. 
Please know that you may stop the interview at any time should you not wish to continue.  You 
may refuse to answer any question in whole or in part. 
If at any point you would like some clarification, please ask. 
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Do you have any questions or concerns before I begin? 
 
Before I start with the questions, I would like to confirm your mailing address so that I may mail 
you more detailed information about the study along with the contact information for the 
researchers in the event you may have any questions in the future, or wish to withdraw from the 
study.  I will also use this address to send you the gift card as compensation for your 
participation. 
 
 
Mailing Address: 
 
 
 
 
 
 
ORAL CONSENT 
 
Note to interviewer: 
 
Please date and sign below indicating that you have read and explained this information to the 
participant before receiving the participant’s consent, and the participant had knowledge of its 
contents and appeared to understand it. 
 
Please record the consent along with the interview.  
 
 
 
         
Name of Participant  Researcher’s Signature  Date 
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Appendix E 
Physician Invitation to Participate Script  
 
 
Hello, this is [interviewer name] calling from the University of Saskatchewan, College of 
Pharmacy and Nutrition. I am calling to speak with Dr. [last name].  Dr [last name] has referred 
patients to our service, and I would like to speak to him/her about those referrals.  Could you 
please have him/her return my call at his/her earliest convenience.  I had sent a fax to the Dr 
about this earlier today/yesterday/this week (will have to confirm when fax is sent). 
 
May have to improvise here to get the receptionists to put your through to the physicians 
 
Then when you get to speak with the Dr.: 
 
Hi Dr. [last name], I am calling regarding your recent experiences with a program within our 
College called Medication Assessment Consultants or MAC. I am working with a research team 
whose purpose is to evaluate the MAC service.  I am calling to see if you would be willing to 
participate in a 5 to 10 minute phone interview about the service. 
If you agree to participate, you will be compensated with a $20 gift card for the Co-op. 
You should be aware that there are no known or anticipated risks to you by participating in this 
research, and the possible benefits of the study, while not guaranteed, include contributing to the 
state of knowledge of such pharmacist-delivered services as MAC.   
Would you be interested in participating?  If now is not a good time for you, we can arrange a 
time and date that is convenient for you. 
 
If the answer is “No.”  Thank them for their time. 
 
If the answer is “Yes, but now is not a good time,” arrange for an agreed upon time and date to 
call back. 
 
If the answer is “Yes and now is a good time,” continue on with the script. 
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The purpose of this interview is to collect feedback and gain a physician-perspective on the 
Medication Assessment Consultants (or MAC) service.  The questions are designed to help 
identify areas of the service that work well and should remain the same, as well as to identify 
areas that could be improved or changed.  You will be asked to answer several short questions.  
Your responses will be recorded and transcribed.   
All identifiers will be removed from the transcribed interviews.  Your patients and MAC 
pharmacist will only receive de-identified information.  This means they will not be able to 
connect or identify your responses with your identity. 
Please know that you may stop the interview at any time should you not wish to continue.  You 
may refuse to answer any question in whole or in part. 
If at any point you would like some clarification, please ask. 
Do you have any questions or concerns before I begin? 
Before I start with the questions, I would like to confirm your mailing address so that I may mail 
you more detailed information about the study along with the contact information for the 
researchers in the event you may have any questions in the future, or wish to withdraw from the 
study.  I will also use this address to send you the gift card as compensation for your 
participation. 
 
Mailing Address: 
 
 
 
 
 
ORAL CONSENT 
Note to interviewer: 
Please date and sign below indicating that you have read and explained this information to the 
participant before receiving the participant’s consent, and the participant had knowledge of its 
contents and appeared to understand it. 
 
Please record the consent along with the interview.  
         
Name of Participant  Researcher’s Signature  Date 
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Appendix F 
Patient Participant Information 
 
Project Title:  
Evaluation of a consultant pharmacist delivered comprehensive medication management service 
     
 
Researcher:  
Julia Bareham, BSc, BSP, MSc Candidate  
Graduate Student 
College of Pharmacy and Nutrition, University of Saskatchewan 
Phone #: 270-0815 
E-mail: julia.bareham@usask.ca 
 
Supervisor:  
Dr. Derek Jorgenson, BSP, PharmD 
College of Pharmacy and Nutrition, University of Saskatchewan  
Phone #: 966-2009 
E-mail: derek.jorgenson@usask.ca 
 
Purpose(s) and Objective(s) of the Research:  
The purpose of this study is to evaluate a model for delivering medication reviews by 
pharmacists as a community-based health service. This model involves a consultant pharmacist 
(a pharmacist that does not work for a drug store or a hospital, but rather is an independent 
pharmacist) within a community pharmacy to provide medication reviews to patients. The 
researchers hope to identify areas of the service that work well, as well as those that could be 
improved or changed. 
Your involvement in the study will contribute to answering the research question: What are the 
experiences of key program stakeholders (e.g. patients and doctors)? 
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Procedures:  
Participation in this study involves a one-on-one phone interview. It is expected that the 
interviews will not last more than 15 minutes.  You will be asked to answer several open-ended 
questions.  All interviews will be recorded and later transcribed.  
It is anticipated that 10-15 participants will be included in the interview process. 
Please feel free to ask any questions regarding the procedures and goals of the study or your role. 
 
Funded by: 
The investigators have received a grant to conduct this study from the Drug Plan and Extended 
Benefits Branch of Saskatchewan Health. The investigators do not perceive any conflict of 
interest on their part or that of the grant providers. 
 
Potential Risks:  
There are no known or anticipated risks to you by participating in this research. 
 
Potential Benefits: 
The possible benefits of the study, while not guaranteed, include contributing to the state of 
knowledge of such pharmacist-delivered services as MAC.  Information gathered from this 
research project may help inform the development of future similar services as well as contribute 
to the improvement of the MAC service should it continue to be funded. 
 
Compensation:  
In order to compensate you for the cost of your inconvenience and time, you will receive an 
honorarium in the amount of $20.  
 A $20 gift card for the Co-op will be sent directly to you via the mail.  
 
Confidentiality: 
To safeguard the confidentiality and anonymity of your responses, your interview will be 
transcribed by a transcriber not otherwise involved with this research project.  Your transcribed 
responses will not include your name or any other identifiable facts that you may reveal 
throughout your interview.  It should also be noted that the interviewer is not involved with the 
delivery of MAC services.  Both the interviewer and transcriber have signed confidentiality 
agreements. 
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All interview recordings and transcriptions will be kept by the researcher’s academic supervisor 
in a locked university office, further secured within a locked filling cabinet.  Any electronic files 
will be kept on a password-protected computer within the same office.  Once five years has 
passed, all materials will be permanently destroyed/deleted.  Data collected from the interviews 
will be presented in aggregate form and will not be individually identified in any reports, 
presentations, articles or any other form. 
 
Right to Withdraw:   
Your participation is voluntary and you can answer only those questions that you are comfortable 
with answering.  You may withdraw from the research project for any reason, at any time 
without explanation or penalty of any sort. 
Whether you choose to participate or not will have no effect on the future care you may receive 
from MAC or your family doctor. 
Should you wish to withdraw during the interview, you can simply tell the interviewer and the 
interview will immediately stop.  All recording will also be immediately and permanently 
deleted.  Should you wish to withdraw after the interview is complete, and before the data is 
analyzed, you will need to contact the primary researcher to inform her of your decision.  Her 
contact information is included below this paragraph.  If you withdraw after completing the 
interview, your interview recording will be permanently deleted and any transcripts will be 
permanently deleted and/or shredded. 
Primary Researcher: 
Julia Bareham, BSc, BSP, MSc Candidate  
College of Pharmacy and Nutrition, University of Saskatchewan 
Phone #: 270-0815 
E-mail: julia.bareham@usask.ca 
 
Your right to withdraw data from the study will apply until the data has been analyzed. After this 
has been completed, it is possible that some form of research dissemination will have already 
occurred and it may not be possible to withdraw your data. 
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Follow up: 
To obtain a summary of the results from the study, please contact Derek Jorgenson. 
Dr. Derek Jorgenson, BSP, PharmD 
College of Pharmacy and Nutrition, University of Saskatchewan  
Phone #: 966-2009 
E-mail: derek.jorgenson@usask.ca 
 
 Questions or Concerns: 
If you have any questions or concerns, please contact the researcher, Julia Bareham, using the 
information listed directly below. 
Primary Researcher: 
Julia Bareham, BSc, BSP, MSc Candidate  
College of Pharmacy and Nutrition, University of Saskatchewan 
Phone #: 270-0815 
E-mail: julia.bareham@usask.ca 
 
This project was reviewed by the U of S Behavioural Research Ethics Board and received an 
exemption in November 2012.  Any questions regarding your rights as a participant may be 
addressed to the Research Ethics Office toll free at 1-888-966-2975 or ethics.office@usask.ca.   
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Appendix G 
Physician Participant Information 
Project Title:  
Evaluation of a consultant pharmacist delivered comprehensive medication management service 
      
 
Researcher:  
Julia Bareham, BSc, BSP, MSc Candidate  
Graduate Student 
College of Pharmacy and Nutrition, University of Saskatchewan 
Phone #: 270-0815 
E-mail: julia.bareham@usask.ca 
 
Supervisor:  
Dr. Derek Jorgenson, BSP, PharmD 
College of Pharmacy and Nutrition, University of Saskatchewan  
Phone #: 966-2009 
E-mail: derek.jorgenson@usask.ca 
 
Purpose(s) and Objective(s) of the Research:  
The purpose of this study is to evaluate a model for delivering medication reviews by 
pharmacists as a community-based health service. This model involves a consultant pharmacist 
(a pharmacist that does not work for a drug store or a hospital, but rather is an independent 
pharmacist) within a community pharmacy to provide medication reviews to patients. The 
researchers hope to identify areas of the service that work well, as well as those that could be 
improved or changed. 
Your involvement in the study will contribute to answering the research question: What are the 
experiences of key program stakeholders (e.g. patients and physicians)? 
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Procedures:  
Participation in this study involves a one-on-one phone interview. It is expected that the 
interviews will not last more than 10 minutes.  You will be asked to answer several open-ended 
questions.  All interviews will be recorded and later transcribed.  
It is anticipated that 10-15 participants will be included in the interview process. 
Please feel free to ask any questions regarding the procedures and goals of the study or your role. 
 
Funded by: 
The investigators have received a grant to conduct this study from the Drug Plan and Extended 
Benefits Branch of Saskatchewan Health. The investigators do not perceive any conflict of 
interest on their part or that of the grant providers. 
 
Potential Risks:  
There are no known or anticipated risks to you by participating in this research. 
 
Potential Benefits: 
The possible benefits of the study, while not guaranteed, include contributing to the state of 
knowledge of such pharmacist-delivered services as MAC.  Information gathered from this 
research project may help inform the development of future similar services as well as contribute 
to the improvement of the MAC service should it continue to be funded. 
 
Compensation:  
In order to compensate you for the cost of your inconvenience and time, you will receive an 
honorarium in the amount of $20.  
 A $20 gift card for the Co-op will be sent directly to you via the mail.  
 
Confidentiality: 
To safeguard the confidentiality and anonymity of your responses, your interview will be 
transcribed by a transcriber not otherwise involved with this research project.  Your transcribed 
responses will not include your name or any other identifiable facts that you may reveal 
throughout your interview.  It should also be noted that the interviewer is not involved with the 
delivery of MAC services.  Both the interviewer and transcriber have signed confidentiality 
agreements. 
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All interview recordings and transcriptions will be kept by the researcher’s academic supervisor 
in a locked university office, further secured within a locked filling cabinet.  Any electronic files 
will be kept on a password-protected computer within the same office.  Once five years has 
passed, all materials will be permanently destroyed/deleted.  Data collected from the interviews 
will be presented in aggregate form and will not be individually identified in any reports, 
presentations, articles or any other form. 
 
Right to Withdraw:   
Your participation is voluntary and you can answer only those questions that you are comfortable 
with answering.  You may withdraw from the research project for any reason, at any time 
without explanation or penalty of any sort. 
Whether you choose to participate or not will have no effect on the future services you may 
receive from MAC.  Your patients will not be informed of your participation in the study, nor 
will they be informed if you decline participation. 
Should you wish to withdraw during the interview, you can simply tell the interviewer and the 
interview will immediately stop.  All recording will also be immediately and permanently 
deleted.  Should you wish to withdraw after the interview is complete, and before the data is 
analyzed, you will need to contact the primary researcher to inform her of your decision.  Her 
contact information is included below this paragraph.  If you withdraw after completing the 
interview, your interview recording will be permanently deleted and any transcripts will be 
permanently deleted and/or shredded. 
Primary Researcher: 
Julia Bareham, BSc, BSP, MSc Candidate  
College of Pharmacy and Nutrition, University of Saskatchewan 
Phone #: 270-0815 
E-mail: julia.bareham@usask.ca 
 
Your right to withdraw data from the study will apply until the data has been analyzed. After this 
has been completed, it is possible that some form of research dissemination will have already 
occurred and it may not be possible to withdraw your data. 
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Follow up: 
To obtain a summary of the results from the study, please contact Derek Jorgenson. 
Dr. Derek Jorgenson, BSP, PharmD 
College of Pharmacy and Nutrition, University of Saskatchewan  
Phone #: 966-2009 
E-mail: derek.jorgenson@usask.ca 
 
 Questions or Concerns: 
If you have any questions or concerns, please contact the researcher, Julia Bareham, using the 
information listed directly below. 
Primary Researcher: 
Julia Bareham, BSc, BSP, MSc Candidate  
College of Pharmacy and Nutrition, University of Saskatchewan 
Phone #: 270-0815 
E-mail: julia.bareham@usask.ca 
 
This project was reviewed by the U of S Behavioural Research Ethics Board and received an 
exemption in November 2012.  Any questions regarding your rights as a participant may be 
addressed to the Research Ethics Office toll free at 1-888-966-2975 or ethics.office@usask.ca.   
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Appendix H 
MAC Staff Participant Information 
Project Title:  
Evaluation of a consultant pharmacist delivered comprehensive medication management service 
     
 
Researcher:  
Julia Bareham, BSc, BSP, MSc Candidate  
Graduate Student 
College of Pharmacy and Nutrition, University of Saskatchewan 
Phone #: 270-0815 
E-mail: julia.bareham@usask.ca 
 
Supervisor:  
Dr. Derek Jorgenson, BSP, PharmD 
College of Pharmacy and Nutrition, University of Saskatchewan  
Phone #: 966-2009 
E-mail: derek.jorgenson@usask.ca 
 
Purpose(s) and Objective(s) of the Research:  
The purpose of this study is to evaluate a model for delivering medication reviews by 
pharmacists as a community-based health service. This model involves a consultant pharmacist 
(a pharmacist that does not work for a drug store or a hospital, but rather is an independent 
pharmacist) within a community pharmacy to provide medication reviews to patients. The 
researchers hope to identify areas of the service that work well, as well as those that could be 
improved or changed. 
Your involvement in the study will contribute to answering the research question: What are the 
experiences of key program stakeholders (e.g. patients, physicians and pharmacists)? 
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Procedures:  
Participation in this study involves a one-on-one in-person interview. It is expected that the 
interviews will not last more than 60 minutes.  You will be asked to answer several open-ended 
questions.  All interviews will be recorded and later transcribed.  
It is anticipated that 3 participants will be included in the interview process. 
Please feel free to ask any questions regarding the procedures and goals of the study or your role. 
 
Funded by: 
The investigators have received a grant to conduct this study from the Drug Plan and Extended 
Benefits Branch of Saskatchewan Health. The investigators do not perceive any conflict of 
interest on their part or that of the grant providers. 
 
Potential Risks:  
There are no known or anticipated risks to you by participating in this research. 
 
Potential Benefits: 
The possible benefits of the study, while not guaranteed, include contributing to the state of 
knowledge of such pharmacist-delivered services as MAC.  Information gathered from this 
research project may help inform the development of future similar services as well as contribute 
to the improvement of the MAC service should it continue to be funded. 
 
Confidentiality: 
All interview recordings and transcriptions will be kept by the researcher’s academic supervisor 
in a locked university office, further secured within a locked filling cabinet.  Any electronic files 
will be kept on a password-protected computer within the same office.  Once five years has 
passed, all materials will be permanently destroyed/deleted.  Data collected from the interviews 
will be presented in aggregate form and will not be individually identified in any reports, 
presentations, articles or any other form. 
 
Right to Withdraw:   
Your participation is voluntary and you can answer only those questions that you are comfortable 
with answering.  You may withdraw from the research project for any reason, at any time 
without explanation or penalty of any sort. 
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Whether you choose to participate or not will have no effect on future employment opportunities 
you may have with MAC.   
Should you wish to withdraw during the interview, you can simply tell the interviewer and the 
interview will immediately stop.  All recording will also be immediately and permanently 
deleted.  Should you wish to withdraw after the interview is complete, and before the data is 
analyzed, you will need to contact the primary researcher to inform her of your decision.  Her 
contact information is included below this paragraph.  If you withdraw after completing the 
interview, your interview recording will be permanently deleted and any transcripts will be 
permanently deleted and/or shredded. 
 
 
 
Primary Researcher: 
Julia Bareham, BSc, BSP, MSc Candidate  
College of Pharmacy and Nutrition, University of Saskatchewan 
Phone #: 270-0815 
E-mail: julia.bareham@usask.ca 
 
Your right to withdraw data from the study will apply until the data has been analyzed. After this 
has been completed, it is possible that some form of research dissemination will have already 
occurred and it may not be possible to withdraw your data. 
 
Follow up: 
To obtain a summary of the results from the study, please contact Derek Jorgenson. 
Dr. Derek Jorgenson, BSP, PharmD 
College of Pharmacy and Nutrition, University of Saskatchewan  
Phone #: 966-2009 
E-mail: derek.jorgenson@usask.ca 
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Questions or Concerns: 
If you have any questions or concerns, please contact the researcher, Julia Bareham, using the 
information listed directly below. 
 
Primary Researcher: 
Julia Bareham, BSc, BSP, MSc Candidate  
College of Pharmacy and Nutrition, University of Saskatchewan 
Phone #: 270-0815 
E-mail: julia.bareham@usask.ca 
 
This project was reviewed by the U of S Behavioural Research Ethics Board and received an 
exemption in November 2012.  Any questions regarding your rights as a participant may be 
addressed to the Research Ethics Office toll free at 1-888-966-2975 or ethics.office@usask.ca.   
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Appendix I 
Instructions for Interview Transcript Analysers 
 
Project Background & Instructions for Interview Transcript Analyzers 
Overview of the research project 
Purpose: to perform a program evaluation to evaluate a consultant-pharmacist model for 
delivering comprehensive medication management (CMM) in the primary healthcare system. 
The CMM service was entitled MAC (Medication Assessment Consultants).  MAC positioned a 
consultant pharmacist within the Co-op grocery store on 8th street (in the Learning Centre room) 
to provide CMM services.  Patients were most frequently referred to the service by their 
physician, but home care or CPAS also referred patients they identified as being a high risk for 
falls due to medications.  Patients were also able to self-refer to the service.  It is important to 
note that the consultant pharmacist was not an employee of Co-op, but was simply using the 
space provided by the company (at no charge). 
 
The program evaluation of MAC aims to answer the following questions: 
 What worked well with MAC? 
 What didn’t work well with MAC?  What were some of the barriers or challenges 
encountered? 
 What were the experiences of the key MAC stakeholders (i.e. patients, physicians & 
MAC staff)? 
o Describe the patient experiences with MAC 
o Describe the physician experiences with MAC 
o Describe the MAC staff &/or admin experiences with MAC 
 Who utilized MAC? 
 Did MAC accomplish what it intended to accomplish? 
The interview transcripts that you will be analyzing will help answer the first three questions 
only. 
The MAC clinic was in operation from September 2011 to February 2013, and while referrals are 
still accepted today, the location and service provider has changed.  Also, the evaluation is not 
examining referrals after the date of February 2013. 
Each of the 3 stakeholder groups was interviewed using a different set of questions/interview 
guide (physician and patient questions were very similar however).  All three interview guides 
have been provided to you. 
The following individuals will be analyzing the following transcripts: 
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Patients  
(9 interviews) 
Physicians  
(5 interviews) 
MAC Staff/Admin  
(3 interviews) 
Jason Jason Jason 
Derek Derek Rob 
Julia Julia Julia 
 
As you read through the transcripts, you will be asked to identify themes that fall into 1 of 5 
categories: 
1. What worked well 
2. What could be improved?  What challenges were identified? 
3. Any suggestions for improvements. 
4. Any other topics/themes that you feel are relevant, but not captured by the above 3 
themes. 
5. Identify any quotes that you feel capture a theme or relevant topic in a noteworthy 
way.  (If you think to yourself, “wow, that person said that very well”, please 
capture/highlight that quote.) 
To help you organize the transcripts into the above 5 categories, you will have 2 tools to assist 
you.  The first tool is a simple document that contains the category as its title (so there will be 5 
documents).  As you read through the transcripts, if you identify a statement that fits into the 
category, you can note it within that document.  We will discuss this during our orientation in 
greater detail.  Your second tool will be colour coding.  As you read through the transcripts, each 
of the 5 categories is assigned a colour (see below) that you can use to highlight the text to make 
referring back to the transcripts easier when we review our findings.  You can do this the old 
fashion way with a highlighter and paper, or do so electronically – whichever you prefer is fine 
with me.  You may also jot down notes in the margins or use the ‘insert comment’ function to 
add in your thoughts or comments. 
Category Colour 
#1 – Worked well Blue 
#2 – Needs improvement/Challenge Orange 
#3 – Suggestions for improvement Pink 
#4 – Other relevant themes Purple 
#5 - Quotes Yellow 
 
Where to start? 
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I suggest you start by simply reading through the transcripts without attempting to identify 
themes to ensure you have a better idea of the content of the interviews and what the responses 
might look like.  Once you have looked through all the transcripts for the first time, now go back 
and start to see if you can identify any themes within the 5 main categories.  You can take an 
interviewee’s statement (might be several sentences) and assign it a theme within a category.  
For example, if a physician said: “I really liked the referral process because I found it to be quick 
and easy to do”, you could identify this theme as ‘convenient, easy referral process’ and place it 
under the category #1 – what worked well. 
Once all three analyzers have finished analyzing a stakeholder group of transcripts, we will meet 
again to ensure our identified themes align/match up.  This is where highlighting the transcripts 
might come in handy, in case you need to refer back to an individual transcript to justify your 
findings.  You might also find it useful to note the source of your identified theme using both the 
transcript identifier and page number.  The transcript identifier is on the top left of every page, 
and the page number is on the bottom right.  When you note it next to your identified theme, it 
will look like: PT – DERE087, p.3 
Jason and Derek, I request that you start with the physician transcripts since they are the shortest. 
Once all three stakeholder group transcripts have been analyzed, there will be a between group 
comparison (versus the previous within group comparison) to see if there is any overlap between 
the 3 groups. 
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Appendix J 
Comprehensive List of All the Documents Identified and Analysed for the Document 
Review 
MAC 
Document Purpose of Document 
Type of Information Contained in the 
Document 
MAC Promotional Materials 
MAC Patient 
Brochure 
Mailed out to patients 
after their initial 
appointment has been 
booked to ensure they 
know when the 
appointment is, what to 
bring and what to expect. 
 Appointment information (date, time, 
location, name of pharmacist with 
whom the patient will meet) 
 MAC contact information (i.e. phone 
number) in the event the patient needs 
to cancel or change his/her appointment
 An explanation of what the patient 
should bring to the appointment 
 An explanation of why the patient has 
been referred to the pharmacist 
MAC 
Promotional 
Poster 
Mailed out to family 
physicians in Saskatoon 
to inform them of the 
service as well as inform 
them that they could now 
refer patients to MAC. 
 An explanation of the service 
 A description of how the MAC service 
can benefit a physician’s practice 
 MAC contact information (phone and 
e-mail address) 
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MAC 
Document Purpose of Document 
Type of Information Contained in the 
Document 
MAC Policy and Procedure Manual 
MAC Policy 
and Procedure 
Manual 
An internal document 
designed to describe the 
service model in detail to 
MAC pharmacists.  The 
manual allows for a 
consistent delivery of 
service. 
 A description of the MAC service 
(what is comprehensive medication 
management, what are the MAC 
service objectives, overview of how the 
service is delivered, reporting structure)
 MAC pharmacist job description, 
responsibilities and qualifications 
 Patient recruitment strategy and how 
the service is promoted to various 
stakeholder groups 
 A detailed description of the referral 
process 
 A detailed description of the patient 
appointment format (includes 
assessment, documentation, 
communication and follow-up) 
 A list of resources required to deliver 
the service 
 Copies of the various documents used 
to deliver the service 
 Appendices contained the following 
sections: 
Referral Form 
MAC Patient Brochure 
Consent Form 
Medication Review Form 
Care Plan Form 
Head-to-toe Assessment Form 
Useful Resources 
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MAC 
Document 
Purpose of Document Type of Information Contained in the 
Document 
MAC Policy and Procedure Manual 
Referral Form 
and MAC FAQs 
(both 
documents were 
contained in one 
double-sided 
document) 
Used both as a 
promotional tool and 
referral tool.  This 
document was the MAC 
service’s referral form 
used to refer patients to 
the service.  It also 
contained frequently 
asked questions about the 
service allowing for the 
service to be both 
explained and promoted. 
Referral Form 
 MAC contact information (phone and 
fax number) 
 Date of referral 
 Physician information (name, clinic 
address, phone number and fax 
number) 
 Patient information (name, date of 
birth, phone number, health card 
number,) 
 Reason for referral (comprehensive 
medication assessment or other 
reason(s)) 
 Urgency of request 
 Explanation of whether or not the 
patient was currently experiencing a 
problem with their medications 
 Request to the physician to fax relevant 
investigations along with the referral 
(e.g. complete list of 
diagnoses/problems, lab values/results, 
etc) 
 
FAQ 
 Who to refer 
 An explanation of what happens during 
an assessment 
 Description of the benefit of the service 
(to both physicians and patients) 
 Description of how the assessment 
findings will be communicated 
 An explanation that no medication 
changes will occur without physician 
consultation 
 Statement that there is no charge to the 
patient for the service 
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MAC 
Document 
Purpose of Document Type of Information Contained in the 
Document 
MAC Policy and Procedure Manual 
MAC Cover 
Letter 
First sheet that 
accompanied all 
physician faxes to help 
physicians identify the 
source of the 
communication. 
 Large MAC logo 
 Contact information (phone and fax 
number) 
 Physician information (name and fax 
number) 
 Comments section 
 Space to indicate the total number of 
pages included in the document 
MAC 
Letterhead 
To be used for all 
external communications 
so that the individual 
who received the letter 
knew that it had come 
from a MAC pharmacist. 
 Blank letter with both the MAC logo 
and name “Medication Assessment 
Consultants” printed at the top 
Letter to 
Physician 
Requesting 
Patient 
Information 
Following a 
CPAS Referral 
When CPAS identified a 
patient to be at risk of a 
fall due to medications 
and referred the patient to 
MAC, this letter was 
used to inform the 
physician of the referral 
as well as request 
relevant patient 
information. 
 The date the letter was sent to the 
physician 
 Physician information (name, clinic 
address, phone number and fax 
number) 
 Patient information (name, date of 
birth, health care number) 
 Subject line stating “Identification of 
Fall Risk by CPAS/Home Care” 
 An explanation of why the patient was 
referred to MAC by CPAS 
 A brief explanation of the MAC service 
 A request for relevant information 
pertaining to the patient and his/her 
medications (e.g. complete list of 
diagnoses/problems, lab values/results, 
etc) 
Patient Release 
of Medical 
Information 
Form 
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MAC 
Document 
Purpose of Document Type of Information Contained in the 
Document 
MAC Policy and Procedure Manual 
Medication 
Review Form 
Tool used to collect 
patient information 
during the assessment.  It 
also served as part of the 
patient record. 
 Reason for the appointment 
 Patient demographics 
 Allergies and past adverse reactions 
 Medication experience (e.g. patient’s 
attitude toward taking medications, 
what does the patient expect from 
his/her drug therapy, etc) 
 Social drug use (e.g. smoking, caffeine, 
alcohol, etc) 
 Past medical history 
 Medications taken in the past 
 Current medications 
 Review of systems 
 Important lab values 
Patient Medical Records 
EMR & 
Shared drive 
Secure location to store 
patient information 
 Patient demographic and health 
information 
Pharmacist Scheduling Tool (Google Calendar) 
Shared 
pharmacist 
calendar 
To coordinate and record 
patient appointments, 
pharmacist availability 
and service room 
availability 
 Date of scheduled appointments 
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Appendix K 
MAC Referral Form 
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Appendix L 
Patient Information Pamphlet 
 
 
 
 
Outside Pages of Brochure 
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Inside Pages of Brochure 
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Appendix M 
 Medication Review Form 
Medication Review Form 
                           
Date: __________________ 
                                                                                               Location: ________________ 
 
 
What is the reason for the referral / encounter today? 
 
Re
as
on
 fo
r 
ap
pt
 
What does the pt hope to achieve with this consultation? 
 
 
Wt  Ht  Age 
Occupation  Living arrangement 
 
D
em
og
ra
ph
ic
s 
Health insurance (coverage issues and affordability of meds) 
 
 
Medication allergies (describe reaction and when experienced) 
 
A
lle
rg
ie
s a
nd
 
A
le
rt
s 
Past adverse reactions (describe reaction and when experienced) 
 
 
What is pts’ general attitude towards taking medication?  Needs attention 
in care plan? 
 
What does the pt want / expect from their drug therapy?   Needs attention 
in care plan? 
 
What is the pts’ primary concern about their medications? 
 
Needs attention 
in care plan? 
 Me
di
ca
ti
on
 Ex
pe
ri
en
ce
 
To what extent does the pt understand their medications? 
 
Needs attention 
in care plan? 
Patient Addressograph (includes name, health #, contact info, etc)
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Smoking / tobacco? 
 
 
Caffeine? 
 
 So
ci
al
 dr
ug
s 
Alcohol / Recreational drug use? 
 
 
 
PM
H
 
Relevant past medical history 
 
 
 
 
 
 
 
 
 
  Meds Taken in past (include why and when stopped) 
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Current Medications                  
(including OTC and herbals) 
Diagnoses / problems (describe history of the problem and its management, 
response to therapy, description of symptoms and disease control) 
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EENT (vision, hearing, or nasal problems; coughing) 
Cardio (chest pain, heart problems, HTN, lipids) 
 
Pulmonary (breathing problems) 
 
GI (stomach problems or pain, nausea, constipation, trouble swallowing) 
 
Skin (any skin troubles) 
 
Endocrine (diabetes, thyroid history) 
 
Hepatic (any history of liver problems) 
 
Diet  (general diet, weight changes) 
 
Reproductive (incontinence, impotence, hot flashes) 
 
Renal / urinary (urinary frequency, renal dysfunction) 
 
Hematology (bruising, bleeding) 
 
MSK (pain) 
 
Neuro (numbness, tingling, balance or falls, memory) 
 
Psych (mood problems) 
ID (any infectious diseases like HIV, Hep C, TB, etc) 
Immunizations 
   Influenza   Pneumovax   
    Other___________________ 
Re
vi
ew
 of
 Sy
st
em
s 
Any additional diagnoses not discussed? 
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* Normal range in brackets may vary with each lab     **Common parameters listed – may need to include other pt specific parameters 
 
Parameter**  Dates 
        
Scr       
Est. CrCl               
(140‐age)(wt)1.23/SCr x 0.85 female        
Urea  (3.7 – 7.0)        
K+ (3.5 – 5.1)        
Na+ ( ‐‐‐ )        
Cl – ( ‐‐‐ )        
ALT ( ‐‐‐ )        
AST ( ‐‐‐ )        
Albumin ( ‐‐‐ )        
GGT ( ‐‐‐ )        
RBC ( ‐‐‐ )        
Hgb ( ‐‐‐ )        
BP        
HR        
LDL        
TC / HDL        
HDL        
Triglycerides        
A1C        
FBG        
ACR (<2.0 men, <2.8 
women)        
Microalbumin (<20)        
INR        
CK (30 ‐ 200)        
TSH (0.3 – 5.5)        
        
        
        
Im
po
rt
an
t la
bs
 / m
ea
su
re
m
en
ts
* 
        
D. Jorgenson, PharmD, 2011  Adapted from Pharmaceutical Care Practice 2nd Ed. Cipolle, Strand, Morley 
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Appendix N 
Physician Mail Out Promotional Poster 
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Appendix O 
MAC Frequently Asked Questions (FAQs) 
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Appendix P 
Client/Patient Access Services (CPAS) Referral Form 
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Appendix Q 
Comprehensive Overview of Patient Data 
MAC 
Patient 
Number 
Sex 
Year 
Of 
Birth 
Referral 
Type 
Physician 
Name 
Number of 
Drugs Patient 
Was Taking 
at Time of 
First 
Appointment 
Number of 
Conditions 
the Patient 
Had at Time 
of First 
Appointment 
Number of 
Recommendations 
Sent to the 
Physician 
1 Male 1936 Physician 22 12 2 0* 
2 Female 1924 Physician 22 15 16 7 
3 Female 1930 Physician 1 23 12 3 
4 Female 1938 Physician 1 31 13 9 
5 Female 1931 Physician 22 19 10 3 
6 Female 1964 Physician 2 16 10 3 
7 Male 1958 Physician 3 19 13 3 
9 Male 1944 Physician 22 15 18 9 
10 Male 1924 Physician 4 21 21 13 
11 Female 1937 Physician 5 24 12 4 
12 Female 1921 Physician 6 22 15 6 
13 Male 1948 Self Not MD referred 7 4 3 
14 Female 1939 Physician 7 23 9 9 
15 Male 1933 Physician 8 12 6 2 
16 Female 1946 Physician 4 26 10 6 
*For MAC Patient 1, no recommendations were made because the patient was referred to the service for 
information about which prophylactic antibiotic would be best for a minor surgery.  Before the MAC pharmacist 
could complete the assessment, the patient was called in form surgery. 
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MAC 
Patient 
Number 
Sex 
Year 
Of 
Birth 
Referral 
Type 
Physician 
Name 
Number of 
Drugs Patient 
Was Taking 
at Time of 
First 
Appointment 
Number of 
Conditions 
the Patient 
Had at Time 
of First 
Appointment 
Number of 
Recommendations 
Sent to the 
Physician 
17 Female 1939 Physician 4 14 6 0 
18 Female 1961 Physician 9 19 11 11 
19 Female 1953 Physician 4 16 18 5 
20 Female 1961 Physician 10 10 2 1** 
21 Male 1952 Physician 10 6 4 5 
22 Female 1970 Physician 10 14 6 5 
23 Female 1946 Physician 11 8 12 8 
24 Male 1930 Physician 11 10 4 N/A 
25 Female 1956 Physician 2 N/A N/A N/A 
26 Female 1923 Home Care 
Not MD 
referred 6 10 N/A 
27 Male 1919 Home Care 
Not MD 
referred 13 13 6 
28 Female 1917 Home Care 
Not MD 
referred 13 12 N/A 
29 Male 1937 Home Care 
Not MD 
referred 6 17 N/A 
30 Female 1923 Physician 12 N/A N/A N/A 
31 Female 1931 Physician 10 5 9 N/A 
32 Female 1935 Physician 13 10 8 6 
33 Female 1925 Home Care 
Not MD 
referred 16 17 5 
34 Female 1940 Home Care 
Not MD 
referred 2 7 4 
**For MAC Patient 20, there was only one drug recommendation made to the physician because the nature of the 
referral was a drug-information question related to natural products causing liver toxicity. 
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MAC 
Patient 
Number 
Sex 
Year 
Of 
Birth 
Referral 
Type 
Physician 
Name 
Number of 
Drugs Patient 
Was Taking 
at Time of 
First 
Appointment 
Number of 
Conditions 
the Patient 
Had at Time 
of First 
Appointment 
Number of 
Recommendations 
Sent to the 
Physician 
35 Male 1933 Home Care 
Not MD 
referred N/A N/A N/A 
36 Female 1960 Physician 15 6 3 N/A 
37 Female 1929 Physician 15 6 11 3 
38 Female 1965 Physician 15 2 5 4 
39 Female 1961 Physician 14 16 5 4 
40 Female 1927 Physician 14 6 7 8 
41 Female 1960 Physician 5 5 5 9 
42 Female 1948 Physician 5 21 11 6 
43 Female 1942 Physician 16 5 6 1 
44 Female 1943 Physician 17 9 9 5 
45 Female 1948 Physician 18 17 5 4 
46 Female 1927 Physician 19 6 5 N/A 
47 Male 1944 Physician 20 6 3 2 
48 Male 1926 Self Not MD referred 7 5 4 
49 Female 1940 Physician 21 20 9 8 
50 Male 1942 Self Not MD referred 13 12 6 
51 Male 1936 Physician 10 12 10 7 
52 Male 1952 Physician 23 18 8 1 
53 Female 1949 Self Not MD referred 25 5 7 
54 Male 1961 Physician 20 N/A N/A N/A 
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Explanation for Missing Data 
 
MAC Patient 8 – This file was created, but no actual patient ever was assigned this number. 
MAC Patient 24 – Patient was unable to attend the clinic. 
MAC Patient 25 – Patient was not interested in the service (patient declined participation). 
MAC Patient 26 – Patient was referred to MAC through home care.  The patient’s physician 
was contacted to request relevant health information, but the physician never replied. 
MAC Patient 28 – Patient was seen form initial appointment, but was unable to attend future 
appointments. 
MAC Patient 29 – Patient was referred to MAC through home care.  The patient’s physician 
was contacted to request relevant health information, but the physician never replied. 
MAC Patient 30 – Patient declined participation because she was recently assessed at the 
Geriatric Assessment Unit (GAU).  Her medications were assessed during her time with GAU. 
MAC Patient 31 – Patient was unable to attend the clinic. 
MAC Patient 35 – Patient was new to the referring physician.  Physician was unable to access 
required medical information from previous physician. 
MAC Patient 36 – Patient was unable to attend the clinic (lives two hours outside of 
Saskatoon). 
MAC Patient 46 – The patient’s physician was contacted to request relevant health information, 
but the physician never replied. 
MAC Patient 54 – Patient was not interested in the service (patient declined participation). 
 
 
 
